hg_51363.1

Basic information about the TSS

---

TSS ID: hg_51363.1 Species: human Chr: chr4		Start: 10116451 End: 10116483 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000514319.5 uc062vei.1 Distance: 0 GeneID: 9948 HGNC/MGI_ID: HGNC:12754 UniProt_ID:

Gene_name: WD repeat domain 1 Gene_symbol: WDR1 Gene_synonyms: Gene_source: HGNC:12754

TATA-Box annotation

---

Distance to TSS:	482
Nearest PromoterID:	NM_017491
Entrez ID:	9948
Nearest Unigene:	Hs.128548
Nearest Refseq:	NM_005112
Nearest Ensembl:	ENSG00000071127
Gene Name:	WD repeat domain 1
Gene Alias:	AIP1
Gene Description:	WD repeat domain 1
Gene Type:	protein-coding
CpG%:	0.145
GC%:	0.820896
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@WDR1 p2@WDR1 p3@WDR1 p4@WDR1 p5@WDR1 p6@WDR1 p7@WDR1 p8@WDR1 p9@WDR1
Sample		p1@WDR1	p2@WDR1	p3@WDR1	p4@WDR1	p5@WDR1	p6@WDR1	p7@WDR1	p8@WDR1	p9@WDR1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	17.92	23.57	22.40	3.70	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	16.99	21.45	19.22	3.64	0.00	0.20	0.00	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	19.29	23.53	22.76	3.28	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	15.80	21.41	14.55	1.46	0.00	0.00	0.21	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	15.97	19.57	15.97	2.25	0.22	0.00	0.00	0.00	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	16.86	19.77	18.02	1.55	0.00	0.00	0.00	0.00	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	15.25	24.62	20.26	6.54	0.00	0.00	0.00	0.00	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	15.99	21.80	18.17	3.63	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	9.19	20.52	20.73	1.28	0.00	0.00	0.00	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	6.38	12.75	8.11	1.16	0.00	0.00	0.00	0.00	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	8.49	17.38	10.11	3.64	0.40	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	10.57	15.45	10.98	0.41	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	62.06	90.27	21.44	7.25	3.39	0.00	1.13	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	59.99	86.75	17.44	9.92	3.76	0.60	1.20	0.15	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	61.26	77.50	21.08	10.32	3.29	0.44	0.88	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	59.85	76.20	16.85	8.55	3.02	0.00	0.50	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	52.85	74.26	16.38	8.95	1.97	0.00	0.22	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	53.15	66.65	13.50	8.44	2.53	0.00	0.42	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	56.51	69.31	17.59	6.40	3.20	0.00	0.53	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	60.78	75.52	21.36	8.42	2.41	0.30	1.50	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	61.35	75.11	20.98	8.29	4.14	0.94	0.53	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	66.11	77.34	20.71	6.90	2.93	0.17	1.21	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	59.33	72.51	17.06	6.72	2.07	0.90	0.65	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	58.24	73.77	19.66	7.77	2.91	0.00	0.49	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	65.27	77.65	21.67	6.45	2.84	1.55	1.55	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	52.22	72.48	20.89	7.60	2.53	0.00	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	51.10	86.27	20.88	10.99	1.65	0.55	0.55	1.10	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	76.38	95.01	20.98	9.67	3.30	0.71	1.18	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	59.93	78.02	18.74	9.53	2.26	0.16	0.16	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	67.68	86.86	20.45	7.24	2.71	0.36	0.72	0.00	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	58.83	80.60	19.89	6.91	2.51	1.47	1.47	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	59.40	91.83	17.78	9.77	2.34	1.17	0.59	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	55.08	79.14	19.84	9.92	0.63	0.42	0.00	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	62.68	82.96	21.11	6.93	1.98	0.99	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	63.20	86.95	20.19	7.29	3.37	0.75	1.50	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	68.03	82.97	18.59	8.24	1.72	0.77	0.96	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	68.26	95.24	21.87	8.79	3.07	1.02	1.23	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	61.86	86.44	18.54	6.45	2.82	1.01	1.01	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	59.96	85.62	19.72	7.56	3.51	1.35	0.54	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	64.10	91.22	21.13	7.92	3.12	0.72	1.20	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	63.28	85.16	19.53	7.29	1.18	1.88	1.18	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	62.22	82.57	19.32	9.22	1.17	0.15	0.59	0.44	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	74.45	101.02	25.31	11.18	3.37	1.90	0.84	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	68.71	98.43	21.33	9.09	3.32	0.52	0.70	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	79.10	102.39	18.67	9.64	3.81	1.00	1.41	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	66.07	105.62	26.29	8.38	4.19	1.40	0.93	0.47	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	67.17	103.40	19.19	10.32	3.84	0.48	1.68	0.00	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	71.83	117.13	25.33	8.64	1.79	0.60	0.60	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	69.66	111.55	23.46	10.29	2.87	0.72	0.72	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	72.39	104.54	23.25	10.51	4.25	1.42	1.62	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	70.71	101.86	24.80	7.99	4.10	2.05	1.23	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	111.41	143.43	26.68	9.78	4.00	3.34	1.56	0.89	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	125.93	125.93	27.98	13.99	13.99	0.00	27.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	64.23	101.84	26.97	9.94	3.55	0.35	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	64.95	101.07	24.85	5.30	2.98	0.99	1.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	89.77	116.61	20.97	2.52	5.03	0.84	0.84	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	84.50	145.58	27.55	10.10	2.30	0.00	1.38	0.46	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	79.08	129.00	24.31	6.16	2.27	1.62	1.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	62.31	112.73	24.41	8.35	5.46	3.21	2.25	0.64	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	119.13	215.00	37.72	8.80	5.34	1.26	0.94	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	108.58	126.20	22.56	6.35	2.12	2.12	2.12	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	76.83	127.30	28.60	6.73	3.36	1.68	3.36	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	120.22	242.82	36.62	8.76	3.98	0.80	1.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	111.44	201.48	34.32	12.91	6.80	1.36	2.04	0.34	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	92.93	153.69	22.42	7.47	4.22	1.95	2.27	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	92.65	126.02	19.52	6.39	2.48	1.42	1.42	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	290.95	371.77	32.33	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	205.33	213.23	31.59	15.79	7.90	0.00	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	78.49	109.20	26.33	4.88	5.85	1.46	0.98	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	70.41	121.98	22.81	7.44	4.46	2.48	0.50	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	80.69	133.23	31.43	5.63	3.28	0.00	1.41	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	84.78	154.00	20.20	6.62	3.31	1.32	1.99	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	60.94	108.89	17.63	6.81	1.86	0.62	0.93	1.86	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	57.17	100.28	17.43	6.11	4.28	1.83	0.92	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	111.34	51.16	18.85	5.54	1.58	2.06	5.54	2.06	0.32
Adipocyte - breast, donor2	11327-117E4	81.18	49.57	14.28	4.33	2.09	1.12	2.41	0.64	0.00
Adipocyte - omental, donor1	11473-119C6	112.60	57.76	20.87	10.94	2.54	2.29	3.18	2.67	0.13
Adipocyte - omental, donor2	11474-119C7	120.35	112.12	26.91	4.48	2.24	4.48	9.72	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	77.37	94.78	18.42	7.70	1.00	0.33	1.67	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	125.05	103.99	19.78	5.10	3.83	2.55	2.55	3.19	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	45.08	30.79	7.70	1.10	0.00	2.20	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	57.81	33.42	8.13	0.90	0.90	0.00	1.81	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	23.11	23.98	7.47	2.95	0.52	0.17	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	62.58	53.00	8.02	4.11	2.54	0.39	0.78	0.20	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	33.46	33.46	10.04	2.32	1.29	0.26	0.77	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	62.17	53.25	7.81	3.35	2.23	0.84	0.28	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	30.57	33.51	4.70	0.59	0.59	0.59	1.18	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	32.41	34.99	4.75	2.65	0.72	0.40	0.16	0.08	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	43.57	35.50	7.10	2.26	0.65	0.00	0.00	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	31.46	28.26	5.87	1.60	0.53	0.00	0.00	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	26.71	20.59	5.01	1.67	0.00	0.00	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	37.43	37.43	7.07	1.66	0.42	0.42	0.42	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	38.43	36.92	5.27	2.26	0.50	0.25	0.25	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	27.82	30.76	8.18	3.60	0.33	0.33	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	18.57	21.92	5.18	3.04	0.30	0.00	0.00	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	136.58	158.90	72.27	21.22	1.55	0.66	1.10	1.10	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	89.65	195.43	51.99	11.47	1.43	0.36	0.00	1.43	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	101.83	69.48	28.75	5.99	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	127.01	71.42	28.07	7.02	2.34	0.72	0.36	0.54	1.62
Amniotic Epithelial Cells, donor2	11613-122A2	66.94	53.55	16.73	6.69	1.67	0.00	0.00	0.00	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	122.45	63.07	25.89	10.48	2.88	1.03	1.44	0.41	0.62
Anulus Pulposus Cell, donor1	11248-116E6	87.88	44.63	16.13	5.26	1.49	0.46	0.80	0.11	0.57
Anulus Pulposus Cell, donor2	11463-119B5	63.92	48.25	14.45	4.41	1.47	0.98	0.73	0.00	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	140.18	64.25	18.87	4.49	2.70	2.25	2.25	4.04	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	123.30	73.37	26.05	6.95	1.30	7.38	1.30	3.47	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	179.78	79.19	21.40	4.28	2.14	4.28	2.14	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	124.65	68.75	20.63	8.67	3.89	4.18	2.09	1.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	127.73	92.32	25.29	7.59	1.26	2.53	2.53	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	159.74	69.31	31.02	11.88	3.30	4.62	1.98	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	130.60	64.65	22.74	7.47	4.22	6.17	2.60	2.92	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	137.38	78.16	20.87	11.65	3.88	3.88	3.88	2.91	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	187.67	64.14	20.19	11.28	2.97	5.34	4.16	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	148.77	74.20	26.36	7.16	3.77	1.13	3.39	2.64	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	129.90	68.94	21.04	9.43	2.90	4.35	3.63	4.35	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	124.12	56.42	18.81	5.02	2.51	7.52	2.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	141.84	59.14	20.26	11.70	1.98	5.60	2.14	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	133.75	61.42	19.11	8.19	1.36	5.46	5.46	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	144.91	81.73	20.96	10.86	3.47	3.92	1.66	0.75	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	156.45	79.83	24.11	5.36	3.21	3.21	2.14	3.75	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	160.22	73.50	22.11	8.31	2.65	5.67	2.83	2.27	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	160.91	62.54	21.12	8.29	4.01	4.28	1.34	0.80	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	118.03	51.70	11.71	5.85	0.98	2.93	2.93	1.95	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	153.92	77.46	21.40	6.47	3.81	6.80	3.98	0.33	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	132.08	55.23	32.42	3.60	2.40	2.40	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	130.99	53.10	38.94	0.00	3.54	3.54	0.00	10.62	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	134.99	65.70	21.78	6.69	3.95	5.83	1.20	0.69	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	146.82	96.48	29.36	0.00	0.00	4.19	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	144.17	57.77	19.90	6.31	3.40	3.40	2.43	2.91	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	161.65	73.99	21.25	5.69	4.55	7.59	3.42	1.52	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	151.42	67.84	23.02	10.90	2.42	8.48	7.27	3.63	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	130.54	79.23	22.80	5.70	1.71	3.99	2.28	3.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	148.15	66.48	22.45	8.34	4.28	5.77	1.71	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	149.43	69.94	19.87	9.81	2.58	4.65	3.10	1.03	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	133.72	64.75	23.46	5.63	2.82	3.28	1.88	2.82	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	129.58	60.13	21.54	6.43	2.89	4.18	0.64	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	168.37	61.36	22.12	9.27	4.28	7.13	2.85	0.71	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	110.56	70.78	16.96	5.26	1.17	6.43	1.17	4.09	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	164.69	66.24	23.78	7.23	3.61	4.22	2.11	2.11	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	196.02	98.60	36.83	10.69	3.56	8.32	9.50	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	154.09	79.84	22.38	9.15	1.53	6.10	3.05	5.09	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	145.43	61.63	19.61	9.17	2.55	5.35	2.55	1.02	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	136.60	64.17	17.79	7.62	1.91	5.72	1.27	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	153.19	76.38	17.69	8.63	0.86	5.61	3.02	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	165.75	68.37	23.07	9.53	3.39	5.50	3.18	1.27	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	149.92	58.58	24.65	8.99	2.03	4.35	1.45	1.16	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	153.05	51.02	27.40	6.61	3.78	6.61	1.89	4.72	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	153.08	66.45	22.04	7.29	2.71	6.61	2.71	1.70	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	152.88	78.76	13.90	20.85	4.63	11.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	141.54	65.49	19.01	6.34	0.00	2.11	6.34	8.45	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	128.22	73.54	22.51	6.86	3.22	6.65	2.79	2.36	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	148.01	51.74	28.88	12.63	3.01	3.61	2.41	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	131.94	64.15	25.51	2.92	3.64	5.10	2.19	7.29	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	153.79	73.56	18.62	8.05	4.60	5.29	2.30	1.61	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	175.97	58.66	20.40	5.10	2.55	7.65	5.10	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	148.47	57.96	23.90	9.66	2.29	4.07	1.78	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	157.51	65.85	20.23	6.81	2.68	6.19	2.27	1.24	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	136.17	55.39	17.14	7.65	3.98	3.37	2.75	0.61	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	138.62	65.01	23.42	7.17	5.26	3.82	3.82	6.69	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	139.47	65.19	18.85	7.32	4.43	4.66	1.11	0.44	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	122.06	64.08	16.78	4.58	4.58	1.53	3.05	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	115.21	62.04	17.17	4.43	3.32	1.66	3.32	2.22	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	141.14	59.31	22.51	7.41	1.59	3.97	3.18	0.79	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	133.02	57.79	19.63	9.81	1.09	3.63	1.45	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	125.76	169.98	73.81	14.37	0.86	0.61	0.74	1.11	1.47
Astrocyte - cerebellum, donor2	11580-120F5	203.68	199.91	80.96	15.23	3.42	3.08	2.05	3.08	0.51
Astrocyte - cerebellum, donor3	11661-122F5	107.60	97.74	47.61	10.70	1.89	1.47	1.68	1.26	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	78.08	111.90	62.40	14.64	1.74	0.00	0.35	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	98.52	106.61	65.03	14.72	2.26	0.81	0.65	0.49	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	137.82	133.50	72.04	14.47	1.79	1.49	0.75	0.60	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	95.42	82.00	25.46	9.06	0.11	0.00	0.00	0.11	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	107.49	90.70	32.07	10.90	0.50	0.00	0.25	0.50	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	92.86	77.84	30.04	8.42	0.57	0.11	0.23	0.34	0.34
Basophils, donor1	12241-129G9	89.97	61.46	22.23	5.49	0.52	0.00	0.00	0.52	1.31
Basophils, donor2	12242-129H1	97.41	45.46	37.52	4.69	0.00	0.00	0.00	0.00	1.08
Basophils, donor3	12243-129H2	69.38	49.10	16.02	3.53	0.29	0.00	0.00	0.73	1.62
Bronchial Epithelial Cell, donor1	11511-119G8	77.40	48.73	39.24	5.82	0.65	0.22	0.00	0.00	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	80.46	50.75	33.37	5.94	0.00	0.00	0.00	1.37	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	7.17	28.69	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	60.88	66.53	17.57	6.28	0.63	0.00	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	121.24	90.67	33.90	8.73	0.42	0.21	0.42	0.62	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	77.61	60.11	31.32	7.60	0.46	0.23	0.00	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	44.63	22.67	26.81	1.80	0.00	0.00	0.00	0.00	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	28.55	21.54	25.87	6.08	0.00	0.00	0.00	0.31	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	38.20	47.98	32.61	6.99	0.47	0.00	0.00	0.23	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	24.94	37.09	51.16	7.35	0.96	0.00	0.00	0.00	2.56
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	20.68	51.71	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	123.42	100.88	19.72	2.25	0.56	0.56	0.56	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	102.08	68.49	22.64	3.90	0.93	0.00	0.19	0.56	0.19
CD14+ Monocytes, donor3	11381-118B4	122.28	83.64	14.71	1.76	0.44	0.00	0.00	0.66	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	62.55	69.91	9.34	4.81	0.57	0.00	0.00	0.00	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	69.75	61.03	21.99	4.93	0.00	0.38	0.38	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	54.90	63.45	13.48	4.93	0.33	0.00	0.00	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	123.88	98.58	17.49	6.22	1.01	0.43	0.87	0.29	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	123.71	68.80	15.39	1.81	0.91	0.30	0.60	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	144.27	77.94	17.77	2.13	0.71	0.00	0.95	0.00	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	120.86	83.36	20.09	5.69	1.34	1.00	0.67	0.84	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	157.88	87.50	15.73	5.80	0.83	0.28	0.28	1.10	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	191.90	120.00	20.83	7.69	0.99	0.25	1.24	0.99	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	138.04	101.82	17.62	6.46	0.78	0.00	0.59	0.78	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	141.19	85.82	13.89	5.52	1.07	0.00	0.71	0.89	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	210.01	114.69	20.89	8.49	1.31	0.44	0.65	0.22	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	124.56	101.14	21.54	7.96	0.47	0.94	1.40	0.47	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	164.22	94.52	23.76	6.86	1.06	1.06	0.53	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	138.67	102.06	24.41	3.33	4.44	0.00	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	123.31	85.23	21.57	6.84	0.89	0.30	0.59	1.19	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	144.87	82.21	18.56	2.99	0.60	0.40	1.00	1.20	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	166.56	81.20	16.66	5.00	0.21	0.42	1.46	0.42	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	204.08	163.12	27.00	11.21	1.83	1.37	1.37	1.83	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	201.77	106.54	22.17	5.43	0.68	0.68	0.45	0.23	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	192.92	103.00	21.39	6.55	1.75	0.44	1.75	1.75	1.75
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	78.28	82.04	16.68	5.11	0.81	0.00	0.54	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	123.34	78.33	14.65	5.23	0.52	0.00	0.00	0.87	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	111.10	65.65	14.31	1.68	0.00	0.00	0.42	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	274.46	194.55	32.88	10.10	1.47	1.29	2.20	0.55	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	319.15	160.63	28.53	11.27	2.82	1.06	2.11	1.06	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	345.28	170.23	24.57	8.77	1.75	1.32	4.39	1.32	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	111.95	99.39	22.84	9.94	1.05	0.35	0.35	0.35	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	104.81	83.26	21.93	5.58	0.37	0.74	1.12	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	163.39	111.65	20.05	6.90	1.94	0.43	0.22	0.22	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	205.56	144.55	25.80	10.65	0.41	0.00	0.41	0.82	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	247.79	123.09	22.72	9.74	1.62	0.23	0.46	0.93	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	280.48	131.31	30.62	11.60	1.86	0.46	1.86	0.46	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	98.74	54.49	7.85	2.83	0.44	0.00	0.22	0.22	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	90.32	70.22	5.54	3.93	0.23	0.23	0.46	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	81.66	53.50	7.58	3.68	0.00	0.00	0.00	0.43	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	88.76	71.63	11.83	3.74	0.00	0.16	0.00	0.31	1.09
CD14+CD16- Monocytes, donor2	11799-124C8	59.03	64.44	9.61	3.49	0.17	0.00	0.00	0.52	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	82.05	71.80	14.49	4.24	0.00	0.00	0.22	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	121.21	68.13	9.44	3.83	0.00	0.00	0.26	0.26	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	112.20	72.68	10.54	3.07	0.00	0.22	0.00	0.88	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	137.07	74.74	7.79	3.37	0.42	0.00	0.00	0.42	0.84
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	40.65	42.68	48.78	6.10	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	44.75	42.03	58.98	4.75	0.68	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	23.82	24.85	52.82	5.18	0.00	0.00	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	45.31	22.92	47.97	8.53	0.00	0.00	0.00	0.00	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	58.97	35.92	70.76	6.43	1.07	0.00	0.00	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	40.01	38.61	65.28	6.32	0.00	0.00	0.00	0.00	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	47.06	39.22	58.04	6.27	0.00	0.00	0.00	0.00	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	44.82	44.82	48.78	0.00	0.00	0.00	0.00	0.00	2.64
CD19+ B Cells, donor1	11544-120B5	37.81	23.01	49.31	3.29	0.82	0.00	0.00	0.00	4.11
CD19+ B Cells, donor2	11624-122B4	39.17	35.55	32.64	1.45	0.00	0.00	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	23.22	22.21	40.89	2.02	0.50	0.00	0.00	0.50	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	26.67	29.50	16.97	0.00	0.00	0.00	0.00	0.00	4.85
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	23.57	23.97	15.58	1.60	0.40	0.00	0.00	0.00	3.99
CD34+ Progenitors, donor1	11545-120B6	40.16	24.10	50.20	2.01	1.00	0.00	0.00	0.00	2.01
CD34+ Progenitors, donor2	11625-122B5	52.81	50.56	49.44	2.25	0.00	0.00	0.56	0.00	3.37
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	43.59	33.44	39.45	5.64	0.00	0.00	0.38	0.00	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	40.59	48.70	42.84	5.41	0.23	0.23	0.23	0.00	1.35
CD4+ T Cells, donor1	11225-116C1	62.48	29.99	83.19	3.57	1.07	0.00	0.00	0.00	4.28
CD4+ T Cells, donor2	11306-117C1	39.80	11.63	110.84	4.29	0.00	0.00	0.00	0.00	2.45
CD4+ T Cells, donor3	11382-118B5	54.59	19.21	131.76	3.66	0.30	0.00	0.00	0.00	3.66
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	86.78	52.83	105.67	5.10	0.26	0.00	0.00	1.02	4.08
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	82.43	58.17	120.38	7.64	0.00	0.00	0.00	0.22	1.80
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	110.10	46.28	117.00	6.61	0.29	0.00	0.00	0.00	2.87
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	30.82	18.96	136.54	2.37	0.00	0.00	0.00	0.00	1.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	35.12	23.18	158.02	4.21	0.00	0.00	0.00	0.70	4.92
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	49.44	13.18	187.88	9.89	0.00	0.00	0.00	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	104.34	59.97	87.72	8.09	0.29	0.00	0.14	0.58	2.31
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	118.79	65.92	170.82	7.63	0.17	0.00	0.17	0.00	2.54
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	138.15	64.64	139.28	7.25	0.48	0.16	0.16	0.16	3.39
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	81.14	33.17	82.04	4.48	0.00	0.00	0.00	0.00	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	56.60	37.38	94.33	4.89	0.00	0.00	0.35	0.35	3.84
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	107.80	49.72	116.16	4.40	0.44	0.00	0.00	0.00	2.64
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	88.97	46.38	122.70	5.90	0.42	0.00	0.00	0.00	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	115.31	63.16	107.83	5.40	0.00	0.21	0.00	0.42	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	130.64	57.80	93.89	6.35	0.33	0.67	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	24.47	15.23	220.81	1.63	0.00	0.00	0.00	0.00	4.08
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	21.44	21.44	233.14	4.29	0.00	0.00	0.00	0.54	4.29
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	43.04	12.55	254.64	1.79	0.00	0.00	0.00	0.00	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	154.09	65.64	129.24	10.38	0.37	0.19	0.00	0.56	2.41
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	111.56	63.47	123.26	6.50	0.22	0.00	0.00	0.00	3.03
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	159.93	76.71	135.13	9.04	0.21	0.21	0.00	1.05	2.94
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	45.50	23.26	142.07	4.55	0.00	0.00	0.00	0.51	2.53
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	54.16	28.16	143.84	2.17	0.00	0.00	0.00	0.00	4.77
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	81.50	34.87	141.64	6.10	0.00	0.00	0.00	0.44	5.23
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	90.56	39.59	175.18	8.91	1.48	0.49	0.00	0.00	3.46
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	92.32	50.78	146.79	1.85	0.00	0.00	0.00	0.00	4.62
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	103.29	36.29	117.25	9.77	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	76.71	65.91	191.36	7.20	0.00	0.00	0.00	0.00	1.94
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	103.55	80.24	213.74	6.38	0.00	0.00	0.00	0.00	1.72
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	113.96	55.44	166.32	10.78	0.00	0.00	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	115.67	45.48	164.02	7.88	0.36	0.00	0.00	0.00	2.51
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	117.72	51.24	153.73	4.15	1.38	0.00	0.00	0.00	4.15
CD8+ T Cells, donor1	11226-116C2	55.00	33.07	72.03	7.20	0.98	0.00	0.00	0.00	2.29
CD8+ T Cells, donor2	11307-117C2	58.94	30.79	68.33	3.75	0.00	0.00	0.00	0.38	4.88
CD8+ T Cells, donor3	11383-118B6	78.78	46.71	78.78	4.80	0.50	0.00	0.50	0.25	3.79
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	122.50	67.21	25.00	4.13	0.23	0.23	0.69	0.92	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	113.11	52.72	21.57	3.35	0.72	0.48	0.48	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	104.51	53.90	25.72	6.57	0.00	0.00	0.27	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	111.38	52.84	21.62	2.40	0.00	0.60	0.30	1.20	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	101.75	52.32	19.68	6.00	0.48	0.24	0.72	0.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	118.47	59.35	23.42	6.37	0.23	0.00	0.91	0.45	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	108.64	58.01	15.64	3.69	0.22	0.22	0.22	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	109.23	52.64	17.63	3.42	0.26	0.26	0.26	0.00	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	102.01	50.19	16.65	4.46	0.23	0.00	0.23	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	95.09	57.66	18.11	5.43	0.60	0.00	0.60	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	98.48	39.51	14.82	3.49	0.00	0.29	0.29	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	96.98	58.35	12.52	2.40	0.00	0.00	0.00	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	68.29	47.71	12.69	1.75	0.44	0.44	1.31	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	72.87	38.71	18.22	3.19	0.00	0.00	1.37	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	58.18	35.06	11.19	3.73	0.75	0.00	1.49	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	130.38	60.15	23.05	10.80	1.44	0.36	0.72	0.72	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	128.61	60.71	23.88	7.48	1.44	0.86	0.86	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	124.21	58.69	22.63	7.78	0.47	0.47	0.00	0.47	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	115.04	57.68	17.43	2.54	0.00	0.00	0.32	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	123.33	51.06	15.69	4.31	0.00	0.00	0.31	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	115.41	62.51	18.91	3.53	0.32	0.00	0.32	0.64	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	81.47	50.49	16.83	4.21	0.00	0.00	0.00	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	93.80	45.72	13.40	1.18	0.00	0.00	0.39	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	65.05	45.38	20.42	1.51	0.76	0.76	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	54.60	46.57	14.45	4.82	0.00	0.80	1.61	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	47.56	46.16	20.98	3.50	0.70	0.70	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	53.09	48.08	18.03	4.01	0.00	0.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	32.90	31.07	10.97	1.83	0.00	0.00	1.83	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	97.83	44.47	22.23	8.40	3.46	1.98	0.99	1.48	0.49
Cardiac Myocyte, donor3	11686-122I3	182.89	72.72	27.26	8.94	2.74	3.16	2.84	1.89	0.11
Chondrocyte - de diff, donor1	11261-116G1	100.19	78.00	14.91	4.85	1.73	2.43	2.43	1.39	0.00
Chondrocyte - de diff, donor2	11338-117F6	80.32	60.41	22.74	5.33	2.84	2.13	1.42	1.78	0.00
Chondrocyte - de diff, donor3	11410-118E6	64.06	38.80	12.74	3.30	2.84	0.91	1.14	0.57	0.23
Chondrocyte - re diff, donor2	11339-117F7	68.93	50.13	12.53	2.69	0.90	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	42.87	35.18	5.66	3.24	0.81	1.21	0.40	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	155.61	92.27	53.13	14.34	1.26	0.80	0.92	0.57	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	175.72	92.35	55.79	16.03	2.78	1.07	1.71	1.92	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	167.35	92.83	52.83	13.81	2.30	1.59	1.15	0.62	0.88
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	53.64	48.97	37.69	9.63	1.19	0.18	0.83	0.83	3.48
Corneal Epithelial Cells, donor1	11526-119I5	76.41	66.75	41.50	5.49	0.00	0.22	0.44	0.44	0.66
Corneal Epithelial Cells, donor2	11606-120I4	52.33	38.68	39.82	1.14	0.00	0.00	0.00	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	103.53	54.45	44.48	5.11	0.51	0.26	0.26	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	152.88	86.01	26.42	6.44	0.33	0.00	0.50	0.50	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	146.67	92.10	22.71	8.20	0.63	0.32	0.63	0.95	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	162.18	106.97	34.51	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	115.66	72.03	22.46	4.54	0.22	0.65	0.43	0.32	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	53.98	33.48	140.76	5.47	1.37	0.00	0.00	0.00	11.96
Dendritic Cells - plasmacytoid, donor2	11309-117C4	51.58	33.95	137.10	6.53	0.00	0.00	0.00	0.00	7.83
Dendritic Cells - plasmacytoid, donor3	11385-118B8	48.39	42.59	174.70	4.36	0.97	0.00	0.00	0.48	11.61
Endothelial Cells - Aortic, donor0	11207-116A1	267.66	96.56	17.84	11.84	4.00	2.17	6.17	3.50	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	169.58	66.31	17.60	7.63	4.11	3.52	1.76	1.76	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	201.63	83.99	24.04	13.57	3.39	5.37	4.81	3.11	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	209.57	59.37	15.73	17.30	5.90	7.47	5.11	5.90	0.00
Endothelial Cells - Artery, donor1	11264-116G4	142.24	64.57	15.42	4.65	7.27	2.33	4.94	4.07	0.00
Endothelial Cells - Artery, donor2	11341-117F9	135.28	77.88	21.65	8.23	3.53	3.29	4.94	2.35	0.00
Endothelial Cells - Artery, donor3	11413-118E9	252.27	86.25	21.21	9.64	4.38	5.43	4.91	4.21	1.05
Endothelial Cells - Lymphatic, donor1	11236-116D3	127.67	49.21	15.74	9.31	3.10	1.55	1.33	3.55	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	130.23	41.68	13.39	8.22	1.22	2.13	2.43	3.96	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	113.04	50.18	14.66	6.20	3.38	1.97	1.13	2.82	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	162.23	91.22	13.67	10.99	3.27	3.86	4.16	3.27	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	170.78	76.54	15.62	10.93	4.69	3.64	2.08	5.21	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	143.77	55.01	14.89	5.96	5.96	2.13	2.84	3.69	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	156.85	110.83	21.61	9.60	5.60	3.20	2.80	4.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	131.03	59.23	16.77	12.58	5.24	2.10	0.52	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	217.56	66.72	25.84	9.32	3.11	2.36	2.48	2.24	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	139.70	43.24	18.68	3.26	2.82	2.17	0.43	1.30	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	161.33	52.39	19.30	8.30	3.05	0.85	2.08	1.83	0.24
Endothelial Cells - Vein, donor1	11267-116G7	151.29	67.11	14.79	9.10	2.28	4.55	5.69	3.41	0.00
Endothelial Cells - Vein, donor2	11344-117G3	213.04	69.15	23.05	11.18	4.89	2.79	3.49	5.59	0.00
Endothelial Cells - Vein, donor3	11416-118F3	202.54	71.44	20.88	9.26	7.54	3.30	3.30	2.51	0.00
Eosinophils, donor1	12244-129H3	167.72	30.49	106.73	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	539.64	283.85	100.67	8.25	0.00	0.00	1.65	0.00	6.60
Eosinophils, donor3	12246-129H5	228.28	149.81	89.17	7.13	0.00	0.00	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	86.98	38.85	30.30	6.84	0.98	0.00	0.00	0.24	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	76.97	45.76	31.20	4.16	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	97.61	81.34	48.81	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	165.03	85.39	12.32	2.87	3.28	5.34	5.34	3.28	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	64.82	49.49	12.81	5.15	3.18	6.79	2.85	2.08	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	134.99	72.04	19.50	7.15	4.33	3.03	1.95	1.41	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	239.41	88.41	38.08	12.86	6.19	7.88	6.91	4.97	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	137.56	80.79	26.20	9.42	1.91	3.82	3.68	2.18	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	106.73	77.31	16.35	6.54	3.38	5.48	2.85	1.16	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	89.06	45.58	16.86	3.43	2.11	1.58	2.11	1.32	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	144.84	85.71	28.24	6.98	5.65	3.32	2.66	1.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	211.84	100.25	34.48	5.44	2.27	6.35	6.80	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	223.59	137.95	33.35	13.64	4.55	3.03	1.52	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	109.30	72.71	23.82	10.09	4.89	3.00	2.84	1.42	0.00
Fibroblast - Cardiac, donor4	11452-119A3	114.27	55.17	14.55	6.97	2.42	1.82	3.33	2.12	0.00
Fibroblast - Cardiac, donor5	11456-119A7	161.17	84.01	21.95	8.38	2.92	3.17	2.41	1.14	0.13
Fibroblast - Cardiac, donor6	11460-119B2	174.03	92.17	31.83	8.64	2.73	5.31	4.24	1.82	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	152.62	111.21	32.16	6.83	0.94	1.07	1.61	2.28	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	91.46	37.10	19.41	3.02	0.43	0.43	0.43	1.29	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	71.77	77.63	58.59	4.39	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	144.61	111.63	37.59	8.07	3.00	0.23	1.15	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	79.54	40.87	10.52	5.60	1.70	1.36	1.02	0.34	0.34
Fibroblast - Dermal, donor1	11269-116G9	98.37	46.02	13.15	2.58	2.82	0.94	0.94	0.94	0.47
Fibroblast - Dermal, donor2	11346-117G5	135.37	76.88	23.11	4.72	3.30	0.47	1.89	1.89	0.00
Fibroblast - Dermal, donor3	11418-118F5	146.88	49.81	13.66	4.96	3.02	1.09	1.81	0.85	0.36
Fibroblast - Dermal, donor4	11450-119A1	59.24	73.25	26.57	3.73	1.47	0.11	0.11	0.11	0.57
Fibroblast - Dermal, donor5	11454-119A5	62.45	94.20	25.82	4.88	1.57	0.17	0.35	0.00	0.35
Fibroblast - Dermal, donor6	11458-119A9	69.52	100.70	32.16	3.57	0.49	0.81	0.65	0.65	0.65
Fibroblast - Gingival, donor1	11237-116D4	106.61	69.34	18.12	5.21	1.46	1.67	0.83	0.83	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	163.75	63.67	14.67	4.98	4.98	4.98	4.19	2.10	0.26
Fibroblast - Gingival, donor2	11318-117D4	139.69	83.29	31.76	5.80	2.50	1.19	0.92	0.26	0.53
Fibroblast - Gingival, donor3	11394-118C8	82.09	58.11	13.73	3.58	1.16	0.48	0.97	0.39	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	105.97	60.26	13.51	1.04	5.19	9.35	5.19	4.16	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	106.43	53.57	11.28	4.05	5.11	8.63	3.52	0.88	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	147.95	97.75	25.72	5.61	3.43	2.81	4.21	0.78	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	160.51	99.39	20.55	7.03	5.14	5.81	5.81	1.49	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	105.16	46.58	13.06	3.18	8.82	12.35	7.76	1.41	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	198.60	99.88	31.88	7.17	9.07	6.00	6.73	1.90	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	166.76	73.09	25.77	6.27	2.45	4.09	5.18	1.23	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	212.26	105.52	29.40	11.19	5.27	6.69	6.47	0.88	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	113.72	64.27	14.97	3.23	7.48	4.55	4.70	0.73	0.00
Fibroblast - Lung, donor1	11270-116H1	134.58	58.45	20.39	2.72	4.08	0.00	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	83.56	47.75	19.40	0.00	1.49	0.00	0.00	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	130.21	63.10	24.90	4.85	2.53	2.11	0.84	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	184.93	193.26	42.48	5.00	5.83	3.33	4.17	1.67	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	152.45	88.11	9.79	5.59	2.80	2.80	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	87.60	63.25	15.67	3.92	3.08	2.24	1.96	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	193.65	112.86	30.85	9.74	4.06	0.41	0.41	1.22	0.00
Fibroblast - Mammary, donor2	11620-122A9	199.71	83.88	19.97	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	184.64	59.56	29.78	17.87	5.96	5.96	11.91	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	129.38	76.62	30.45	6.98	1.75	0.97	1.36	0.39	1.55
Fibroblast - Periodontal Ligament, donor2	11319-117D5	105.27	90.86	40.35	6.83	1.67	0.76	0.46	0.15	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	100.36	71.30	15.91	5.81	2.75	2.75	1.84	1.53	1.53
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	168.68	80.52	27.86	5.72	7.25	9.92	3.43	2.29	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	223.55	112.32	27.81	8.37	7.29	7.83	7.29	1.89	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	125.60	64.83	14.15	5.45	8.12	5.22	3.25	1.04	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	168.78	71.40	25.31	10.06	5.75	4.20	2.87	1.77	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	202.38	120.29	33.73	9.14	3.86	2.64	2.44	1.02	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	163.71	90.88	30.07	6.01	2.67	1.34	2.67	1.34	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	98.84	52.19	18.19	6.33	1.19	1.19	1.58	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	134.55	125.42	39.29	7.94	0.99	2.18	3.97	1.39	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	90.94	77.09	14.92	6.75	3.91	1.78	1.42	1.95	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	142.69	75.68	21.29	8.47	2.76	1.77	2.76	0.79	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	113.72	129.97	37.91	10.83	2.41	0.60	4.21	1.50	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	108.71	102.77	20.83	6.48	2.59	2.37	1.40	0.43	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	156.15	138.18	28.85	7.09	1.52	1.52	3.04	0.76	0.00
Fibroblast - skin normal, donor1	11553-120C5	118.96	89.91	19.69	6.23	3.94	2.95	2.63	1.31	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	178.45	82.01	36.29	11.23	1.80	4.01	7.02	3.01	0.00
Fibroblast - skin normal, donor2	11561-120D4	189.67	112.12	29.13	8.04	2.91	4.22	4.02	2.61	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	193.13	107.60	39.59	9.37	2.12	2.72	4.53	1.81	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	135.87	72.41	14.91	7.54	3.15	1.91	2.24	0.75	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	117.61	68.55	15.90	3.93	2.05	2.74	1.37	0.34	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	136.63	98.20	39.41	4.27	1.64	1.64	6.24	1.97	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	243.93	151.58	37.39	10.55	5.22	8.20	6.39	2.88	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	226.54	124.66	39.30	11.81	6.58	6.92	8.60	3.20	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	136.12	94.56	18.98	5.18	2.67	1.88	3.14	2.20	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	642.63	132.96	44.32	0.00	0.00	66.48	22.16	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	38.35	24.40	14.82	3.49	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	125.51	77.49	29.47	10.75	1.73	1.56	0.87	0.69	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	155.88	71.57	29.93	10.67	3.38	1.82	0.52	0.52	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	129.80	73.84	27.85	6.90	2.81	1.79	0.77	0.51	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	63.54	111.77	124.02	12.25	2.30	1.53	0.77	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	58.70	84.23	105.28	24.25	0.64	0.00	0.00	0.00	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	59.05	103.27	231.92	14.83	0.57	0.00	0.00	0.29	2.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	32.26	64.53	81.90	8.00	0.00	0.28	0.00	0.28	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	32.42	62.56	63.93	9.36	1.60	0.46	0.00	0.23	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	44.98	91.73	148.00	19.02	0.20	0.20	0.00	0.20	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	38.06	59.21	83.27	5.02	0.53	0.26	0.00	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	36.53	67.84	57.40	11.09	1.63	0.33	0.33	0.33	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	46.43	86.23	170.26	18.13	0.88	0.44	0.00	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	41.27	39.43	119.84	6.78	0.57	0.00	0.00	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	48.52	43.72	86.69	6.28	0.37	0.49	0.12	0.00	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	39.49	46.47	92.41	9.94	0.81	0.00	0.27	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	61.95	58.35	86.73	8.05	0.12	0.00	0.00	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	72.40	60.08	108.11	9.41	0.69	0.14	0.00	0.28	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	52.86	49.81	90.47	9.96	0.81	0.20	0.00	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	49.51	46.32	49.74	8.44	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	73.00	61.04	58.42	7.10	0.75	0.00	0.12	0.37	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	66.45	62.08	80.00	9.40	0.66	0.22	0.22	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	46.39	40.48	31.91	7.68	0.30	0.89	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	56.75	49.28	48.96	4.61	0.32	0.00	0.00	0.00	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	41.78	38.65	45.58	6.70	0.45	0.00	0.22	0.00	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	48.59	48.39	29.04	6.65	0.40	0.20	0.00	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	68.87	43.26	40.04	5.60	0.17	0.00	0.51	0.00	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	73.42	55.86	41.50	11.35	0.62	0.09	0.00	0.09	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	54.42	42.98	23.62	8.64	0.31	0.00	0.10	0.31	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	48.50	43.72	24.59	7.17	0.34	0.00	0.00	0.34	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	55.33	43.60	24.68	5.09	0.33	0.22	0.00	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	58.57	43.93	30.03	7.15	0.67	0.33	0.33	0.08	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	52.68	37.16	31.65	7.96	0.61	0.00	0.00	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	49.51	35.69	20.84	7.43	0.41	0.00	0.00	0.00	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	51.19	31.82	27.09	5.65	0.35	0.12	0.12	0.00	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	51.03	40.86	23.35	5.34	0.50	0.50	0.00	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	39.24	33.29	21.60	5.51	0.66	0.22	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	55.47	36.90	28.29	5.66	0.12	0.12	0.00	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	46.68	35.66	21.56	6.48	0.16	0.16	0.00	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	40.41	33.35	27.90	4.81	0.32	0.00	0.00	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	63.58	47.76	27.10	6.16	0.38	0.09	0.38	0.00	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	49.98	43.18	19.93	5.69	0.32	0.00	0.00	0.16	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	51.69	43.79	25.85	4.87	0.30	0.61	0.00	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	61.05	53.11	26.55	6.17	0.10	0.00	0.10	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	45.45	40.84	18.88	5.27	0.44	0.00	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	44.61	38.72	22.16	4.21	0.56	0.28	0.28	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	83.42	58.33	27.68	4.35	0.83	0.37	0.46	0.28	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	67.39	45.46	23.53	9.09	0.27	0.27	0.27	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	70.54	56.15	20.50	6.27	0.15	0.61	0.00	0.15	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	89.64	57.51	24.09	5.05	0.91	0.52	0.65	0.00	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	66.96	51.50	15.18	6.78	0.27	0.00	0.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	72.45	52.17	19.17	6.45	0.92	0.00	0.18	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	71.93	46.27	21.71	8.77	0.66	0.88	0.44	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	68.43	32.73	20.83	7.93	0.99	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	99.73	62.39	20.97	5.94	2.51	1.06	0.92	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	87.16	54.88	21.59	8.07	1.41	1.01	1.41	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	78.79	55.41	26.18	8.90	0.51	0.00	0.25	0.00	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	45.58	74.85	155.66	14.33	0.40	0.00	0.00	0.00	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	39.44	42.22	140.98	7.40	0.31	0.00	0.15	0.00	0.92
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	49.51	57.90	189.03	13.91	0.41	0.41	0.00	0.00	1.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	46.94	83.87	108.90	15.33	1.56	0.31	0.00	0.00	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	38.99	55.38	98.33	12.15	0.57	0.00	0.00	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	29.98	50.73	103.77	7.38	0.46	0.00	0.00	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	39.60	49.50	69.29	4.95	0.00	0.00	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	48.74	48.35	78.14	10.06	0.39	0.39	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	48.13	36.90	51.34	22.46	1.60	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	33.04	67.81	55.64	3.48	1.74	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	43.94	44.59	60.54	8.46	0.33	0.00	0.00	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	42.42	44.47	62.59	5.35	0.82	0.00	0.00	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	56.65	53.32	10.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	40.27	47.82	42.23	6.99	0.28	0.00	0.00	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	41.51	39.55	47.72	7.52	0.33	0.00	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	20.13	32.71	47.81	5.03	0.00	0.00	0.00	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	34.35	47.07	37.85	5.73	0.32	0.00	0.00	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	36.34	43.14	45.51	8.49	0.34	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	27.15	39.67	52.20	2.09	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	28.06	38.94	38.37	5.73	0.00	0.00	0.00	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	27.82	38.77	38.48	6.22	0.30	0.00	0.30	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	32.19	44.05	35.58	10.16	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	39.76	45.56	33.97	4.56	0.00	0.00	0.00	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	37.51	43.03	31.07	5.98	0.23	0.00	0.00	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	79.03	31.61	5.27	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	24.60	33.06	28.06	4.23	0.38	0.00	0.00	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	27.06	38.79	21.84	4.24	0.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	24.08	41.47	12.04	7.36	0.00	0.67	0.67	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	18.11	29.28	19.65	8.09	0.39	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	89.69	80.79	40.05	11.64	2.74	1.37	0.68	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	22.36	32.30	24.85	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	21.71	23.59	24.54	6.13	0.00	0.47	0.00	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	19.31	27.16	16.90	6.03	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	19.84	35.61	24.93	3.56	0.00	0.00	0.51	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	17.95	31.51	21.94	1.60	0.40	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	17.76	27.13	19.73	3.45	0.49	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	29.51	41.32	22.43	4.72	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	20.42	29.76	23.34	2.33	0.58	0.00	0.00	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	19.31	30.72	16.68	5.71	0.00	0.00	0.00	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	24.58	34.76	20.34	1.70	0.00	0.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	34.62	38.80	26.26	7.76	0.00	0.00	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	26.69	34.45	18.44	5.82	0.00	0.49	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	115.27	98.15	22.83	6.85	2.28	4.57	10.27	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	184.21	73.60	17.88	6.65	5.82	9.98	6.65	4.16	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	236.14	104.57	20.24	16.87	6.75	10.12	3.37	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	95.15	37.43	13.00	4.76	1.90	1.59	2.22	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	100.68	30.91	17.13	2.51	0.84	2.92	1.25	2.09	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	34.23	36.44	13.00	4.06	0.35	0.58	0.70	0.35	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	35.95	35.95	15.53	4.22	0.68	0.17	0.51	0.51	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	32.76	31.17	12.29	2.50	0.68	0.00	0.23	0.23	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	35.74	37.60	14.98	4.59	0.55	0.11	0.22	0.44	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	33.31	41.69	17.19	3.87	0.21	0.00	0.64	0.21	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	32.72	29.28	14.42	4.09	0.43	0.22	0.22	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	31.88	32.01	13.20	3.74	0.12	0.25	0.12	0.62	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	27.10	32.08	11.67	3.09	0.34	0.17	0.69	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	27.23	32.36	10.57	2.24	0.00	0.96	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	104.65	80.59	24.62	10.07	5.60	1.12	1.68	2.24	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	137.63	113.39	35.06	9.95	6.06	2.16	3.46	1.73	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	116.33	7.93	5.29	2.64	0.00	2.64	5.29	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	167.90	114.99	40.21	11.99	5.29	4.23	1.76	1.06	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	201.24	87.91	27.61	7.27	7.27	3.63	2.18	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	86.55	41.44	16.78	3.15	1.22	0.87	0.70	0.17	0.17
Hepatocyte, donor1	11523-119I2	14.53	20.58	9.68	2.42	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	35.55	39.86	10.77	4.31	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	20.86	20.25	5.52	1.23	0.00	0.00	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	7.18	10.44	107.04	0.65	0.00	0.00	0.00	0.00	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	44.57	29.01	15.21	3.85	0.00	0.00	0.00	0.17	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	131.99	54.06	33.62	6.59	1.10	0.55	1.23	0.55	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	54.13	54.13	41.39	3.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	60.08	40.05	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	81.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	41.53	41.53	35.99	1.38	1.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	35.04	30.03	27.53	2.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	23.74	35.60	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	66.64	48.70	38.44	5.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	54.85	32.00	50.28	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	64.97	42.23	43.86	3.25	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	46.68	33.35	46.68	3.33	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	50.83	50.83	32.68	7.26	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	63.53	46.32	56.91	6.62	0.00	0.00	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	55.43	37.69	22.17	6.65	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	78.57	41.91	26.19	5.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	64.25	44.72	23.93	5.04	0.00	0.00	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	54.13	46.40	29.39	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	29.27	58.54	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	69.77	48.45	34.24	3.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	45.08	66.01	41.86	3.22	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	83.64	47.79	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	77.41	61.12	35.04	4.89	0.00	0.00	0.00	0.00	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	68.43	60.03	43.66	8.40	0.84	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	71.86	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	83.58	35.36	29.74	6.43	0.00	0.00	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	31.39	41.55	36.01	1.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	15.08	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	60.89	30.68	28.32	2.83	0.00	0.00	0.00	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	38.09	39.91	27.21	2.72	0.00	0.00	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	29.48	44.23	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	61.34	58.11	26.90	4.30	0.00	0.00	0.00	0.00	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	52.09	41.93	30.49	3.81	0.00	0.00	0.00	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	164.30	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	81.62	46.55	45.28	7.65	0.64	0.00	0.00	0.00	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	58.33	41.92	25.52	7.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	31.61	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	63.55	46.41	36.42	6.43	0.00	0.00	0.00	0.71	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	66.37	69.68	26.55	6.64	0.00	0.00	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	70.07	33.03	32.72	5.25	0.00	0.00	0.00	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	40.39	47.41	22.83	3.51	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	53.43	40.86	22.00	6.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	65.37	44.50	37.55	2.09	1.39	0.00	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	30.98	61.97	28.77	4.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	32.42	58.36	32.42	9.73	0.00	0.00	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	44.47	37.49	33.13	7.85	0.00	0.00	0.00	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	42.75	38.25	33.75	2.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	45.30	31.36	6.97	0.00	0.00	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	45.87	46.94	21.34	3.20	0.00	0.00	0.00	0.00	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	26.32	58.19	16.63	2.77	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	42.74	34.20	34.20	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	52.46	36.82	19.33	3.68	0.00	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	69.58	45.38	21.18	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	55.88	49.67	6.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	27.49	44.41	31.72	6.34	0.00	0.00	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	106.65	42.92	25.30	5.30	0.49	0.57	0.24	0.16	0.65
Keratinocyte - epidermal, donor2	11349-117G8	83.75	55.05	24.60	5.86	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	101.94	54.43	46.38	5.96	0.57	0.09	0.09	0.28	0.47
Keratinocyte - oral, donor1	11251-116E9	127.48	55.85	62.66	9.88	0.45	0.34	0.11	0.00	1.59
Keratocytes, donor1	11527-119I6	132.72	100.05	24.41	3.78	5.85	1.03	1.38	0.34	0.69
Keratocytes, donor2	11607-120I5	120.70	66.79	28.12	5.86	2.34	2.34	1.17	1.17	1.17
Keratocytes, donor3	11688-122I5	51.97	30.43	9.09	2.57	0.59	0.00	0.40	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	65.94	72.53	21.98	2.20	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	128.37	63.65	46.39	6.47	2.16	0.00	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	63.43	60.66	32.06	9.80	0.46	0.23	0.35	0.35	0.69
Lens Epithelial Cells, donor3	11690-122I7	124.93	83.35	49.24	10.70	2.62	3.53	2.02	1.21	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	118.10	57.98	17.79	9.01	2.25	0.83	2.61	1.66	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	82.61	40.47	14.23	6.14	1.12	0.84	3.63	2.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	121.84	36.99	17.32	5.04	1.42	1.26	1.57	2.20	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	82.81	44.63	12.37	5.38	1.08	0.00	0.00	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	92.03	50.11	17.33	6.93	1.26	0.32	0.63	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	118.49	39.14	17.14	6.79	1.73	0.54	1.83	2.26	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	82.49	42.68	11.08	4.10	1.64	0.41	2.46	1.23	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	95.82	51.83	15.67	10.11	2.28	1.77	2.28	3.03	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	112.18	41.24	17.03	5.07	1.13	0.84	1.83	1.55	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	85.83	43.51	14.24	4.35	2.77	0.79	0.79	1.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	86.67	41.88	12.80	6.20	1.55	0.58	2.33	1.74	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	113.31	34.81	15.55	5.74	1.85	1.11	1.30	1.67	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	90.24	47.04	14.29	6.27	1.39	0.35	1.05	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	91.83	43.17	14.31	8.11	1.67	0.72	1.19	3.10	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	106.72	36.95	14.97	9.06	1.24	0.55	1.79	1.51	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	84.69	48.97	11.70	5.24	2.77	1.23	2.16	1.54	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	94.77	35.23	9.98	8.42	1.56	0.31	0.94	0.94	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	129.37	39.16	16.29	4.76	1.83	1.46	0.55	1.46	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	92.48	43.77	13.16	5.27	1.65	0.66	2.30	0.66	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	84.05	47.15	15.23	7.32	1.76	1.46	0.59	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	126.21	42.82	16.93	8.71	1.00	0.75	3.24	2.99	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	76.14	44.13	15.03	3.88	2.91	0.00	3.88	3.39	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	88.87	44.16	11.04	4.85	1.62	0.54	1.89	2.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	124.43	40.87	14.68	5.75	2.12	1.67	1.67	2.88	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	84.50	39.40	14.52	6.22	2.59	1.56	2.59	2.07	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	91.50	40.20	17.59	8.38	0.84	1.88	1.88	2.51	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	106.61	43.01	15.34	6.47	1.50	0.75	2.71	1.65	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	92.18	50.21	9.63	6.88	0.69	0.00	2.06	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	82.03	42.33	11.48	6.40	1.69	0.38	2.26	3.01	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	122.46	39.13	15.69	6.47	2.33	0.85	2.01	1.70	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	78.99	35.86	14.54	8.24	1.45	0.00	2.42	1.94	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	83.03	37.05	12.24	4.96	2.65	0.66	1.32	1.32	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	120.55	38.53	14.00	5.70	1.73	0.74	1.86	1.24	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	92.55	42.57	17.77	5.18	3.33	0.74	0.37	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	85.49	43.24	10.62	7.41	0.49	0.00	2.47	1.48	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	119.07	35.06	14.57	4.81	2.06	0.69	1.51	1.24	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	80.09	44.06	14.80	5.79	3.54	0.00	2.57	3.22	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	91.30	45.04	14.61	7.91	0.91	1.22	2.13	1.83	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	114.63	36.25	13.16	6.58	1.26	1.12	1.26	2.10	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	82.13	43.73	17.42	3.20	1.42	1.07	1.78	1.78	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	73.20	39.27	13.57	6.79	2.42	0.00	3.88	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	116.08	38.12	16.03	5.91	1.87	0.78	1.09	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	84.51	44.76	14.32	6.45	2.51	1.43	1.43	1.79	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	93.76	42.47	14.05	8.82	1.63	0.65	2.29	2.29	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	109.71	37.20	15.77	5.89	2.59	0.94	2.12	2.59	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	114.97	56.43	14.36	7.18	2.23	0.99	1.86	1.98	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	84.52	41.75	15.37	3.84	1.79	0.77	2.05	1.28	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	114.87	46.25	15.22	3.58	1.19	0.30	0.60	1.79	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	47.59	58.92	18.13	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	38.36	35.29	14.58	5.37	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	25.98	30.43	11.88	1.48	0.00	0.00	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	48.24	32.58	20.31	5.08	0.00	0.42	0.00	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	42.90	28.13	14.77	2.11	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	45.76	29.89	17.75	2.80	0.00	0.00	0.93	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	43.28	23.70	18.55	3.61	0.52	0.52	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	44.01	24.98	10.71	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	45.69	30.76	22.62	4.30	0.23	0.00	0.90	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	54.68	29.37	18.32	2.33	0.58	0.00	0.00	0.29	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	47.27	26.56	17.11	4.95	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	62.05	40.37	21.54	7.18	0.81	0.27	1.22	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	58.54	36.46	20.54	2.57	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	42.34	35.29	18.35	2.47	0.35	1.06	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	31.98	30.65	15.33	1.33	0.00	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	48.90	35.15	20.38	5.60	0.00	0.00	0.51	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	41.35	32.28	20.28	3.74	0.00	0.27	0.00	0.00	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	52.90	35.90	24.00	3.21	0.38	0.76	0.76	0.19	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	60.74	34.36	18.41	3.68	0.61	0.00	0.61	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	54.63	30.99	22.02	1.63	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	58.93	33.32	19.78	3.33	0.00	0.21	0.42	0.21	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	59.14	36.43	18.78	7.29	0.56	0.00	0.28	0.00	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	42.24	31.94	21.64	2.06	1.03	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	65.32	35.71	21.77	3.48	0.58	0.29	0.58	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	49.32	30.19	17.34	2.69	0.90	0.00	0.00	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	50.35	31.54	16.60	2.77	1.11	0.00	0.00	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	63.27	31.11	19.80	8.13	0.00	0.00	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	53.47	33.19	24.34	3.32	0.74	0.37	0.37	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	44.90	26.48	11.51	2.30	0.00	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	44.13	30.32	20.72	5.76	0.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	49.82	28.87	20.38	4.53	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	40.20	36.10	11.49	1.64	0.00	0.00	0.00	0.00	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	47.45	23.05	23.50	3.62	0.00	0.00	0.00	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	49.55	27.29	20.83	2.15	0.00	0.00	2.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	50.04	31.37	20.17	2.99	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	52.39	34.93	18.58	3.34	0.00	0.00	0.37	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	59.44	34.03	21.54	3.45	0.43	0.00	0.00	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	42.81	33.40	21.41	2.57	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	63.30	33.32	22.66	1.33	1.00	0.33	0.33	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	46.45	33.18	15.69	4.22	0.60	0.00	1.21	0.00	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	51.19	34.84	19.91	4.27	0.00	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	61.87	25.44	18.56	4.47	0.34	0.00	0.00	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	50.45	48.31	27.91	3.22	0.00	0.00	0.54	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	47.81	30.30	22.89	2.02	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	65.93	30.74	17.41	3.70	0.37	0.00	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	56.98	32.56	27.91	1.16	0.00	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	42.31	33.85	19.04	1.06	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	58.42	32.81	19.21	3.60	0.00	0.00	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	48.70	32.71	18.90	5.09	0.73	0.73	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	61.32	40.63	26.83	6.13	0.77	0.00	0.00	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	50.81	33.05	24.17	2.47	0.99	0.49	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	47.05	16.94	23.52	6.59	0.94	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	67.38	46.76	27.15	4.53	2.01	2.51	0.00	0.50	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	70.75	39.65	23.43	4.06	0.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	60.24	29.26	32.70	5.16	1.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	77.94	48.99	29.39	4.90	0.45	0.89	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	73.51	30.89	25.81	7.04	0.39	0.78	0.78	0.78	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	56.74	37.60	30.35	5.28	3.30	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	84.07	41.00	29.06	3.63	0.52	1.04	0.52	1.04	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	94.51	41.57	28.44	3.94	1.31	0.44	1.31	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	65.41	36.34	26.84	7.27	0.00	0.56	0.00	1.12	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	78.17	43.72	24.29	5.30	0.88	0.88	1.32	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	95.27	35.10	28.93	3.86	0.00	1.16	2.31	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	86.08	47.09	20.25	6.08	0.00	0.51	2.03	1.01	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	75.46	44.22	24.03	3.84	0.96	0.48	0.00	0.96	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	74.34	33.00	23.46	5.57	1.19	0.00	0.40	0.00	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	72.31	37.67	24.91	8.51	0.61	0.00	1.22	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	58.10	59.49	27.67	4.84	1.38	0.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	91.96	37.62	24.32	7.22	0.00	1.14	1.52	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	72.81	40.28	26.85	7.23	1.55	0.52	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	71.95	52.00	24.79	5.44	2.42	0.00	0.60	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	66.23	39.93	24.40	3.80	0.32	1.27	0.63	0.32	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	78.90	36.25	22.92	5.86	1.07	0.00	0.53	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	66.09	47.70	26.43	5.75	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	80.73	33.94	36.00	7.71	0.00	1.54	1.54	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	70.03	26.17	20.51	5.66	0.00	0.00	0.00	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	72.07	49.94	20.43	6.81	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	68.64	24.55	16.22	4.16	0.00	0.00	2.08	0.83	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	59.51	33.67	19.58	5.48	0.00	0.00	0.78	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	70.98	47.60	24.22	4.18	0.00	0.00	0.42	0.00	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	68.30	38.56	24.16	2.32	0.00	0.93	0.93	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	68.24	28.10	23.42	6.02	0.67	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	79.13	50.26	24.59	4.28	0.00	0.00	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	81.63	34.35	29.90	6.06	1.21	0.00	0.40	0.00	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	78.01	46.81	26.62	1.84	0.00	0.00	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	88.91	76.46	30.23	3.56	0.00	0.00	0.00	0.00	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	99.16	50.72	34.76	6.27	0.57	0.00	2.28	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	111.20	42.18	39.88	6.14	2.30	0.00	3.07	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	91.38	77.15	20.25	3.28	0.55	0.00	1.09	1.09	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	103.34	52.12	26.73	6.24	0.89	0.00	1.78	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	135.18	59.53	36.39	11.18	1.04	0.78	1.04	1.04	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	112.07	74.27	29.18	9.95	1.33	0.00	0.66	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	108.09	29.10	41.57	18.71	2.08	2.08	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	70.88	59.71	11.62	4.79	0.91	0.00	0.46	0.46	0.46
Macrophage - monocyte derived, donor2	11313-117C8	100.56	77.26	34.68	6.24	0.55	0.37	0.55	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	82.97	77.47	24.38	4.46	0.66	0.00	0.13	0.52	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	115.76	45.67	25.49	6.37	2.66	1.06	1.06	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	152.11	94.28	25.83	5.55	2.69	2.22	0.32	0.63	0.00
Mallassez-derived cells, donor3	11930-125I4	167.06	104.80	41.28	8.90	1.95	2.50	0.14	0.56	0.28
Mammary Epithelial Cell, donor1	11273-116H4	125.35	47.23	23.72	7.47	1.20	0.30	0.00	0.10	0.60
Mammary Epithelial Cell, donor2	11350-117G9	84.26	43.43	22.30	4.05	0.00	0.00	0.58	0.00	0.87
Mammary Epithelial Cell, donor3	11422-118F9	133.69	82.06	36.92	7.98	0.50	0.75	0.50	0.00	1.00
Mast cell - stimulated, donor1	11487-119E2	215.58	103.72	37.96	10.85	6.10	4.75	14.24	6.10	0.68
Mast cell, donor1	11563-120D6	105.22	65.53	16.44	4.65	1.08	0.65	0.76	0.22	0.11
Mast cell, donor2	11565-120D8	67.46	58.84	13.37	2.97	0.30	0.00	0.59	0.00	1.78
Mast cell, donor3	11566-120D9	58.76	56.06	15.98	2.93	0.23	0.00	0.45	0.68	1.13
Mast cell, donor4	11567-120E1	66.13	48.22	11.17	2.84	0.35	0.35	0.18	0.00	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	67.31	66.87	18.19	4.44	0.11	0.22	0.11	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	50.78	42.03	16.93	5.84	0.58	1.17	2.33	1.75	0.58
Mast cell, expanded, donor5	11939-126A4	59.31	76.06	13.77	4.36	0.34	0.00	0.11	0.00	0.23
Mast cell, expanded, donor8	11941-126A6	51.05	69.79	12.55	3.01	0.84	0.17	0.17	0.00	0.50
Melanocyte - dark, donor1	11502-119F8	129.84	44.18	17.81	6.77	1.49	0.70	0.99	1.19	0.90
Melanocyte - dark, donor2	11582-120F7	96.21	52.26	27.34	6.92	1.73	1.38	2.42	1.38	0.00
Melanocyte - dark, donor3	11663-122F7	98.37	74.18	22.75	5.51	0.94	0.07	1.01	0.14	0.22
Melanocyte - light, donor1	11274-116H5	79.45	56.18	12.93	4.47	0.71	0.47	0.00	0.24	0.00
Melanocyte - light, donor2	11351-117H1	83.94	88.04	19.11	6.14	1.36	2.73	2.05	0.00	0.68
Melanocyte - light, donor3	11423-118G1	95.39	61.57	11.27	0.87	2.60	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	97.46	70.08	28.53	5.62	1.15	0.31	0.21	0.10	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	76.92	49.22	12.37	7.53	0.54	0.00	0.27	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	63.48	59.20	19.02	3.21	0.80	0.54	0.27	0.27	0.00
Meningeal Cells, donor1	11493-119E8	339.68	180.38	69.23	14.14	1.74	2.48	3.47	4.22	0.62
Meningeal Cells, donor2	11573-120E7	158.89	139.53	50.62	11.00	0.00	0.88	2.20	3.08	0.00
Meningeal Cells, donor3	11654-122E7	255.34	74.00	45.64	13.94	1.96	2.61	3.83	4.32	0.65
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	163.11	67.01	33.08	7.13	1.71	1.71	2.28	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	101.64	51.22	17.61	5.74	2.31	3.02	1.91	0.70	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	42.05	38.11	10.51	1.31	2.63	0.00	1.31	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	107.27	64.10	37.94	5.23	0.00	1.31	2.62	0.00	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	115.53	55.26	18.66	5.74	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	139.34	64.17	22.02	7.62	4.02	3.18	1.69	1.06	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	190.00	84.95	20.11	5.03	6.03	3.02	1.51	2.51	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	159.10	94.93	50.54	9.45	2.20	0.66	1.98	1.10	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	233.06	98.63	45.30	8.77	2.92	2.19	2.19	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	196.42	79.39	42.56	7.98	2.86	2.05	1.84	1.64	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	92.80	60.80	16.48	5.54	1.94	1.25	0.97	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	48.32	64.31	16.36	6.32	1.86	1.49	1.86	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	69.08	51.58	12.24	5.26	1.58	1.05	0.66	0.13	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	35.91	28.19	5.64	2.97	0.59	0.30	0.59	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	44.38	25.69	2.34	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	167.78	73.01	39.06	9.61	2.56	1.28	0.64	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	128.31	56.36	23.75	6.03	1.06	0.71	0.71	1.06	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	65.05	52.22	12.51	3.13	0.94	0.31	1.56	1.56	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	86.36	56.60	25.40	0.73	0.73	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	98.38	92.28	23.87	8.22	4.24	2.92	0.27	0.53	0.00
Mesothelial Cells, donor2	12156-128G5	133.62	97.09	26.02	15.01	3.00	2.00	6.01	1.50	0.00
Mesothelial Cells, donor3	11402-118D7	100.23	83.25	23.78	8.82	5.42	4.48	4.12	0.51	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	68.87	70.22	16.20	2.70	2.70	0.00	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	77.58	95.55	32.51	5.17	0.99	0.00	0.49	0.74	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	87.45	65.66	41.52	9.13	0.29	0.29	0.88	1.47	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	51.86	20.74	10.37	10.37	0.00	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	56.72	70.36	23.87	4.03	0.31	0.31	0.93	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	68.66	56.84	28.83	6.22	1.04	0.62	1.04	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	57.90	25.48	9.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	62.06	80.08	25.28	7.26	1.50	0.00	0.50	0.75	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	77.27	63.77	25.60	3.72	0.93	0.47	1.86	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	97.33	38.93	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	61.57	65.44	23.17	5.08	0.81	0.20	0.81	0.41	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	80.38	64.54	32.86	7.92	0.79	0.79	1.58	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	8.55	8.55	0.00	0.00	0.00	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	53.10	62.83	16.81	4.42	1.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	83.59	69.15	35.71	8.36	1.52	1.14	1.14	1.14	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	59.22	48.69	11.84	7.90	0.00	2.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	65.15	73.22	18.68	6.15	0.85	0.85	1.49	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	58.01	35.91	17.50	2.76	0.00	0.92	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	64.68	78.98	22.95	5.07	1.49	0.89	0.89	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	50.30	51.98	10.06	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	75.27	70.75	26.60	5.52	1.25	0.75	0.75	1.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	68.45	49.20	25.67	6.18	1.19	0.48	0.95	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	79.06	32.62	11.06	1.11	0.00	0.00	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	69.76	73.45	24.64	4.84	0.69	0.23	1.38	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	78.25	63.10	31.13	7.99	0.84	0.63	0.84	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	89.68	54.22	21.40	4.48	1.43	0.61	1.22	1.02	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	75.73	63.07	23.38	3.86	0.21	0.21	0.21	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	68.91	54.91	23.56	7.34	1.78	0.44	0.44	0.67	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	61.91	0.00	0.00	0.00	0.00	0.00	0.00	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	66.14	64.17	21.03	3.72	1.97	0.66	1.75	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	67.43	47.65	19.77	4.06	1.52	1.01	0.00	0.51	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	51.37	36.45	16.57	4.97	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	63.60	67.95	22.02	5.44	0.82	0.82	1.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	75.87	57.35	32.64	7.35	0.59	0.00	0.59	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	64.33	22.90	11.99	3.27	0.00	0.00	2.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	56.71	61.99	24.03	3.84	1.44	0.00	0.96	0.96	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	82.45	54.03	31.22	8.40	0.00	0.00	1.20	1.60	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	49.36	32.91	19.20	5.48	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	73.58	65.58	30.03	6.51	0.50	0.00	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	107.79	80.84	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	65.23	40.77	10.19	2.04	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	64.37	62.62	20.14	5.69	0.44	0.00	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	47.46	50.77	22.07	3.31	0.00	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	59.56	50.59	12.17	4.48	0.64	1.28	1.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	70.90	69.67	26.03	6.20	1.49	0.50	1.24	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	61.24	77.94	25.75	3.48	1.39	0.00	1.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	35.36	44.20	11.05	0.00	4.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	60.85	88.89	20.51	6.15	1.37	0.00	0.34	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	61.70	70.89	18.82	3.50	0.44	0.88	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	60.72	62.85	11.72	1.42	2.49	0.71	0.36	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	75.19	95.67	29.46	4.49	1.68	0.28	0.84	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	68.58	64.42	30.76	4.16	0.83	1.25	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	53.03	55.94	10.49	1.17	0.58	1.17	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	65.46	92.31	21.42	4.22	2.41	0.30	0.60	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	91.83	80.56	29.22	2.09	0.42	0.00	0.42	0.83	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	43.31	7.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	36.94	74.81	24.01	0.92	2.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	89.35	82.52	22.76	5.12	0.00	0.00	1.71	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	71.16	67.02	14.79	2.76	0.69	0.14	1.24	0.69	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	60.12	76.71	21.77	4.66	0.52	0.00	0.78	1.04	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	66.06	97.81	21.88	5.58	0.43	1.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	36.21	28.58	9.53	3.18	0.00	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	41.90	65.92	16.01	3.47	0.53	0.00	0.53	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	62.56	92.49	24.55	3.29	0.90	0.00	1.20	0.90	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	47.18	50.15	11.02	2.12	0.71	0.42	0.14	0.57	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	52.87	71.98	22.93	4.14	0.96	0.32	2.23	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	84.03	101.72	27.42	5.75	0.66	0.00	1.11	0.00	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	45.88	48.54	12.13	3.79	1.14	0.38	0.38	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	53.98	75.00	23.58	4.55	0.57	0.57	0.00	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	79.89	102.75	32.45	4.67	1.97	0.49	0.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	34.54	35.84	5.87	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	41.16	73.51	13.53	2.94	1.76	0.00	0.29	0.59	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	58.82	96.30	26.53	3.75	1.15	0.00	0.86	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	45.34	47.40	12.36	4.53	0.82	0.41	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	35.44	61.64	12.51	4.47	0.00	0.00	0.00	0.89	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	37.67	33.90	7.53	3.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	80.20	73.07	7.13	5.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	73.93	84.11	11.50	4.93	0.99	0.33	0.33	0.33	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	63.12	93.62	19.99	6.31	1.05	1.05	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	65.04	90.54	13.64	5.34	1.38	0.59	0.59	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	100.58	126.66	30.73	13.04	0.93	0.00	0.93	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	102.14	94.26	18.40	4.51	1.50	0.75	0.75	1.50	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	90.02	72.98	27.17	4.53	0.80	0.27	0.00	0.27	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	52.93	73.18	9.39	4.18	0.68	0.11	0.00	0.00	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	69.25	78.09	12.52	2.21	1.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	64.86	85.01	10.63	5.86	1.83	0.37	0.73	1.83	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	79.34	71.56	15.56	6.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	48.63	65.20	6.95	1.60	0.00	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	73.41	69.55	3.86	0.00	0.00	0.00	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	82.82	119.17	18.18	5.05	1.01	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	66.62	61.56	16.02	2.95	0.00	0.00	0.84	0.42	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	19.07	24.51	2.72	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	10.17	1.91	1.91	0.00	0.00	0.00	0.64	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	8.91	5.67	0.81	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	25.68	9.06	4.53	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	68.52	51.39	0.00	5.71	0.00	5.71	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	32.62	22.84	29.36	3.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	61.78	19.01	0.00	0.00	0.00	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	25.10	12.55	0.00	0.00	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	175.80	109.01	31.67	9.26	5.60	7.11	8.62	6.46	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	102.95	101.91	18.81	3.14	3.66	1.57	0.00	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	65.41	50.06	11.35	4.00	4.67	4.00	4.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	108.52	69.28	12.10	2.92	5.01	7.51	6.26	2.09	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	203.26	150.59	27.00	8.94	7.23	5.13	3.99	2.85	0.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	157.99	118.09	47.88	1.60	7.98	6.38	1.60	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	46.92	34.00	8.16	2.72	0.68	3.40	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	161.71	62.48	16.54	11.03	3.68	0.00	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	46.46	48.55	10.04	4.60	5.02	3.35	1.26	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	134.12	93.67	17.90	8.60	4.88	5.35	5.58	1.39	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	67.29	57.83	9.46	3.78	4.86	2.97	3.24	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	76.53	59.08	20.39	4.41	2.73	1.05	1.47	1.26	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	155.89	100.21	33.40	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	59.07	54.60	19.36	3.47	3.47	1.99	2.48	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	82.82	77.68	13.53	3.79	1.62	1.35	0.81	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	80.25	59.16	11.33	4.08	3.63	4.08	2.95	0.68	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	73.49	51.28	9.31	3.27	5.39	3.43	1.31	0.98	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	66.16	56.50	9.84	3.46	3.83	1.09	1.28	0.55	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	50.39	46.15	10.08	3.18	1.06	2.12	1.06	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	41.42	36.02	5.40	0.60	6.60	1.80	4.20	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	71.54	74.17	6.89	3.28	2.30	0.98	1.64	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	72.37	51.39	5.85	2.76	7.32	6.67	2.60	0.65	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	57.50	53.97	10.94	4.06	1.23	1.23	1.23	0.53	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	37.27	32.35	7.03	2.11	5.63	1.41	4.22	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	55.62	51.49	10.57	4.60	3.22	2.30	1.84	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	52.70	51.09	10.28	2.89	2.57	1.93	0.64	0.96	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	152.44	118.99	11.38	5.17	4.14	1.72	2.07	2.07	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	139.06	83.44	17.70	2.53	7.59	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	54.80	52.35	10.03	3.79	3.12	2.01	2.23	0.45	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	40.65	48.69	11.85	5.93	3.81	2.12	1.27	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	71.68	53.40	5.46	2.61	4.51	2.37	1.90	0.47	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	64.82	47.22	10.73	3.00	3.43	3.43	0.86	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	108.33	54.17	0.00	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	51.32	57.31	9.00	3.67	1.33	1.33	0.33	1.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	45.99	41.03	10.82	3.61	0.45	1.80	1.35	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	49.20	40.87	11.51	4.36	1.98	2.38	1.19	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	53.86	44.57	12.07	1.86	1.86	7.43	2.79	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	59.78	54.49	8.32	4.16	1.14	1.14	0.76	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	49.53	39.76	5.87	3.58	0.98	3.58	1.96	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	26.15	28.76	3.49	2.61	1.31	0.00	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	58.80	51.56	14.02	4.07	0.45	0.90	1.81	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	35.28	48.50	13.23	3.53	0.88	1.76	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	49.86	42.55	7.98	0.66	3.99	5.32	1.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	37.20	34.72	5.95	1.49	1.98	0.99	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	35.60	35.22	6.13	4.21	2.68	2.68	0.77	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	60.19	55.95	9.38	3.02	0.60	0.91	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	57.47	49.29	16.80	3.54	1.11	0.88	0.00	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	37.27	35.24	8.13	4.74	2.03	0.00	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	102.19	71.53	10.22	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	31.70	26.22	6.10	2.44	0.00	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	40.29	35.57	7.24	4.09	3.15	2.20	0.00	0.00	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	24.51	25.12	8.17	4.24	1.51	0.91	0.61	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	44.30	41.93	11.08	7.12	2.37	0.79	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	74.82	81.62	14.74	6.80	1.13	1.13	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	151.74	50.58	5.06	10.12	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	140.38	57.64	25.47	8.70	1.99	3.98	3.35	1.61	0.00
Myoblast, donor2	11322-117D8	111.05	49.10	21.29	4.41	1.92	1.73	2.69	0.77	0.96
Myoblast, donor3	11398-118D3	109.14	64.74	27.41	5.89	3.20	2.69	1.68	0.50	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	86.98	79.53	26.12	5.69	0.15	0.15	0.29	0.15	0.15
Natural Killer Cells, donor1	11230-116C6	67.35	46.74	52.28	4.31	0.62	0.00	0.00	0.00	1.54
Natural Killer Cells, donor2	11311-117C6	76.90	31.36	63.33	5.43	0.30	0.30	0.30	0.30	2.71
Natural Killer Cells, donor3	11387-118C1	92.21	49.33	38.65	2.76	0.74	0.00	0.37	0.74	1.84
Neural stem cells, donor1	11275-116H6	85.29	66.06	62.79	9.07	1.45	0.36	0.73	0.00	0.73
Neural stem cells, donor2	11352-117H2	36.59	63.55	92.43	1.93	1.93	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	66.00	54.62	133.13	10.24	3.41	0.00	2.28	0.00	2.28
Neurons, donor2	11574-120E8	28.62	31.04	69.35	7.05	0.66	0.00	0.22	0.00	1.32
Neurons, donor3	11655-122E8	76.46	55.91	138.95	16.44	0.00	0.82	1.64	0.82	1.64
Neutrophils, donor1	11233-116C9	171.68	111.36	77.95	6.50	0.93	0.00	0.00	0.00	4.64
Neutrophils, donor2	11314-117C9	173.93	101.46	55.08	14.49	2.90	0.00	0.00	0.00	5.80
Neutrophils, donor3	11390-118C4	226.62	134.39	102.62	13.44	1.22	0.00	0.61	0.61	9.16
Nucleus Pulposus Cell, donor1	11252-116F1	62.57	42.86	11.52	4.87	1.31	0.71	0.83	0.24	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	67.73	22.14	15.63	2.60	0.33	0.00	0.98	0.33	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	90.25	71.60	17.85	4.21	2.01	1.60	1.00	1.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	120.17	68.69	11.84	6.06	7.30	4.40	3.72	0.55	0.00
Olfactory epithelial cells, donor2	11934-125I8	154.44	77.87	20.26	5.93	6.37	5.36	4.20	1.88	0.00
Olfactory epithelial cells, donor3	11935-125I9	125.20	65.15	14.53	5.22	4.54	2.95	2.61	1.25	0.00
Olfactory epithelial cells, donor4	11936-126A1	157.00	94.38	16.36	7.60	9.35	8.57	6.43	2.43	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	116.15	74.02	28.29	7.82	0.60	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	155.90	56.15	22.12	11.27	3.83	6.38	5.74	3.62	0.21
Osteoblast - differentiated, donor2	11353-117H3	67.44	34.29	18.29	10.29	0.00	1.14	1.14	3.43	0.00
Osteoblast - differentiated, donor3	11425-118G3	45.31	26.07	4.34	3.10	0.00	0.62	0.62	0.62	0.00
Osteoblast, donor1	11277-116H8	267.94	137.20	47.69	18.76	8.99	8.01	5.08	4.10	0.78
Osteoblast, donor2	11354-117H4	210.70	96.22	34.41	8.43	6.32	6.32	7.02	3.51	0.00
Osteoblast, donor3	11426-118G4	300.54	128.85	38.57	14.04	4.80	5.15	2.49	1.07	0.18
Pancreatic stromal cells, donor1	11249-116E7	142.95	56.10	13.81	4.63	2.86	3.12	2.70	1.10	0.25
Pericytes, donor1	11491-119E6	65.09	64.09	24.48	4.78	0.33	0.22	0.45	1.00	0.33
Pericytes, donor2	11571-120E5	40.97	63.84	25.35	4.53	0.45	0.23	0.00	0.23	0.00
Pericytes, donor3	11652-122E5	315.35	99.28	40.49	13.83	6.51	8.34	7.12	6.51	0.41
Perineurial Cells, donor1	11499-119F5	194.62	68.94	37.86	9.95	1.36	1.58	2.15	3.50	0.45
Perineurial Cells, donor2	11579-120F4	126.98	56.22	27.33	8.19	2.58	3.68	2.67	1.20	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	66.62	54.50	67.89	4.78	0.64	0.32	0.00	0.00	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	64.40	38.69	46.03	2.45	0.49	0.00	0.00	0.00	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	59.27	40.12	54.74	3.36	0.39	0.00	0.26	0.13	1.29
Placental Epithelial Cells, donor1	11278-116H9	74.62	55.01	20.81	4.07	1.43	0.24	0.48	0.24	1.67
Placental Epithelial Cells, donor2	11355-117H5	42.14	45.46	18.85	4.44	5.54	0.00	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	59.68	51.44	25.92	4.32	0.98	0.20	0.39	0.20	1.18
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	91.45	69.30	12.34	6.65	3.48	3.48	2.85	1.27	0.00
Preadipocyte - breast, donor1	11467-119B9	90.23	37.14	12.76	5.44	2.81	1.50	3.00	2.06	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	146.19	82.10	27.67	6.92	2.48	3.26	6.40	3.52	0.26
Preadipocyte - breast, donor2	11328-117E5	110.77	63.49	21.39	4.50	3.15	3.38	4.50	0.68	0.23
Preadipocyte - omental, donor1	11468-119C1	83.01	40.17	13.43	5.33	1.49	2.34	2.45	2.77	0.96
Preadipocyte - omental, donor2	11329-117E6	142.29	70.71	23.57	9.17	5.67	6.55	4.80	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	185.79	88.53	34.24	11.03	6.30	7.88	8.17	2.86	0.29
Preadipocyte - perirenal, donor1	11469-119C2	131.89	110.24	25.59	4.92	3.94	0.00	4.92	7.87	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	187.65	92.14	26.10	8.29	3.99	3.99	2.76	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	117.93	86.06	27.98	6.91	3.72	3.90	2.48	0.89	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	112.39	62.66	19.58	4.60	2.04	1.19	1.19	0.51	0.17
Preadipocyte - visceral, donor1	11280-116I2	125.38	81.88	24.40	6.52	4.38	3.45	3.07	1.58	0.65
Preadipocyte - visceral, donor2	11357-117H7	137.13	55.22	21.17	2.30	2.30	1.38	1.38	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	138.97	94.15	29.78	5.12	4.39	3.45	3.03	1.57	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	50.38	36.36	22.33	4.07	0.00	0.00	0.00	0.30	0.30
Prostate Epithelial Cells, donor2	11331-117E8	90.05	40.49	26.00	5.96	1.08	0.41	0.95	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	47.58	32.39	17.82	3.31	0.06	0.00	0.00	0.06	0.31
Prostate Stromal Cells, donor1	11254-116F3	158.55	86.91	32.35	7.29	5.24	5.13	3.64	1.37	0.11
Prostate Stromal Cells, donor2	11332-117E9	131.78	79.61	26.36	8.25	4.12	2.15	4.12	0.54	0.00
Prostate Stromal Cells, donor3	11405-118E1	119.60	58.50	17.62	4.07	3.75	2.50	3.65	1.04	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	108.76	108.03	63.14	9.49	1.46	0.36	0.00	0.36	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	82.20	75.48	40.82	7.62	0.28	0.14	0.07	0.21	0.14
Renal Epithelial Cells, donor1	11517-119H5	123.26	106.01	59.35	11.67	1.52	0.51	0.00	1.52	2.03
Renal Epithelial Cells, donor2	11597-120H4	157.20	113.10	50.50	13.52	0.71	0.71	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	103.32	59.39	38.43	9.10	0.42	0.00	0.00	0.11	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	155.92	110.30	25.19	4.09	4.09	1.36	1.36	3.40	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	179.51	90.29	26.41	7.95	2.96	1.62	1.35	1.08	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	141.42	69.71	31.30	6.88	4.22	2.00	3.11	1.33	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	111.79	36.60	13.31	5.99	2.00	0.67	2.00	2.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	151.42	132.49	54.80	11.00	2.64	1.76	2.42	1.10	0.66
Renal Mesangial Cells, donor2	11598-120H5	156.12	129.16	57.68	13.79	1.25	0.00	0.63	2.51	0.63
Renal Mesangial Cells, donor3	11679-122H5	111.80	101.81	44.11	12.48	2.50	0.28	1.11	1.11	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	120.25	140.12	59.05	9.93	1.07	0.81	0.27	0.54	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	80.12	98.68	41.33	10.96	1.69	0.00	0.00	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	181.85	123.42	60.36	13.31	2.70	2.31	0.96	0.19	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	64.30	63.01	36.04	6.22	0.52	0.26	0.26	0.26	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	111.14	79.30	49.17	12.51	0.85	0.28	0.28	1.14	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	93.65	90.56	51.46	9.26	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	81.80	36.63	33.37	11.29	0.00	0.00	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	47.04	32.61	9.76	2.94	0.53	0.67	0.67	0.80	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	35.74	86.66	20.55	8.04	0.00	0.89	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	21.46	53.94	7.15	2.75	0.00	0.00	1.65	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	31.90	53.37	12.76	2.90	0.58	1.16	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	28.87	140.43	22.10	6.63	1.17	0.65	0.91	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	56.70	116.19	22.74	8.64	0.40	0.40	0.70	0.70	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	65.36	125.26	24.09	12.83	1.34	0.56	0.78	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	61.53	167.09	29.40	10.67	0.37	0.37	1.12	0.50	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	61.19	134.26	27.04	11.07	1.63	0.82	1.17	0.47	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	63.79	107.25	24.73	10.63	0.92	0.69	0.69	0.23	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	34.36	108.84	24.51	5.20	0.68	0.55	0.82	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	66.11	119.05	28.29	9.53	1.66	0.91	1.06	0.61	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	71.68	135.65	27.60	9.14	2.33	1.08	0.72	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	39.16	135.71	25.68	7.75	0.43	0.57	0.72	0.43	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	62.35	126.42	24.79	7.40	0.97	1.50	1.07	0.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	61.07	121.03	25.00	9.51	0.89	1.33	0.89	0.66	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	25.04	112.03	24.09	5.35	0.19	0.38	0.38	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	57.20	126.61	22.36	8.20	0.75	1.02	0.37	0.47	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	69.15	115.56	26.49	10.90	1.32	0.19	0.00	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	38.48	142.79	26.01	5.71	1.06	0.80	0.80	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	67.75	140.95	24.04	7.98	0.97	1.46	1.36	0.29	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	63.21	128.13	28.45	8.78	1.34	0.76	0.57	0.76	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	39.73	130.29	25.95	7.26	1.50	0.43	0.64	0.53	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	57.46	119.69	25.51	8.97	0.84	0.56	0.28	0.28	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	56.74	120.31	31.10	10.60	1.71	0.51	2.05	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	39.57	129.64	26.98	10.03	0.91	1.28	1.46	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	57.39	120.30	24.53	8.58	1.10	0.98	0.49	0.49	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	69.85	144.39	30.49	11.55	1.61	1.75	1.48	0.27	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	29.01	117.94	30.90	5.66	0.24	0.47	0.71	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	62.10	130.95	26.19	9.72	1.79	0.99	0.60	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	66.88	133.99	31.10	11.93	1.87	1.17	0.94	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	42.72	123.58	30.48	9.33	1.24	0.62	1.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	48.89	120.34	28.31	8.63	0.88	0.44	2.43	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	61.83	112.38	23.81	11.91	3.55	1.67	1.25	0.42	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	44.55	146.70	28.80	7.94	1.21	0.81	2.02	0.40	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	60.11	120.40	21.80	5.79	2.21	1.02	1.02	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	62.08	117.80	27.18	10.80	1.54	2.51	1.54	1.16	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	40.75	126.20	29.23	7.39	1.89	0.69	1.38	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	62.00	106.58	24.69	8.64	1.78	1.10	0.69	0.69	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	70.43	113.11	23.80	9.69	1.97	1.81	0.99	0.49	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	30.00	102.60	21.99	5.97	0.34	0.85	0.34	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	59.04	130.94	27.08	8.88	1.78	0.59	0.59	0.74	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	46.11	105.02	21.32	9.86	0.53	0.53	1.60	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	14.93	77.71	11.06	4.56	0.28	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	43.10	111.43	21.67	6.90	0.71	0.00	0.48	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	45.35	96.34	20.56	7.26	0.81	0.20	1.21	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	28.72	103.78	17.05	6.03	0.66	0.66	0.75	0.28	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	35.29	69.52	11.53	5.94	0.35	0.00	0.00	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	31.73	56.21	11.48	4.84	0.60	0.30	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	39.65	130.34	19.58	7.83	1.59	0.49	0.86	0.24	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	57.20	80.49	17.47	8.44	1.31	0.73	0.29	0.15	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	43.20	93.70	17.64	6.08	0.61	0.00	0.00	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	32.55	112.42	17.78	6.33	1.81	0.00	1.51	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	44.11	84.59	15.83	4.52	0.45	0.45	0.45	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	56.91	91.96	19.77	5.39	0.00	0.90	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	25.50	92.81	13.58	4.72	0.00	0.47	0.24	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	48.03	80.26	14.73	5.76	0.64	0.43	1.07	0.85	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	52.29	75.72	15.02	6.61	0.60	0.60	0.60	0.60	0.00
Schwann Cells, donor1	11498-119F4	136.73	147.26	52.85	8.28	2.07	0.75	0.75	1.32	0.94
Schwann Cells, donor2	11578-120F3	88.46	81.66	40.83	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	101.43	45.79	28.48	4.38	1.31	0.44	0.00	0.66	0.44
Sebocyte, donor1	11220-116B5	195.01	102.43	57.52	9.31	1.64	0.00	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	94.67	54.23	30.33	5.06	0.46	0.46	0.00	0.46	1.38
Sebocyte, donor3	11378-118B1	83.27	46.79	32.36	3.30	0.21	0.41	0.00	0.41	0.82
Sertoli Cells, donor1	11255-116F4	218.67	120.93	24.85	14.91	8.28	9.94	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	149.69	42.37	28.24	5.65	0.00	5.65	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	75.40	56.83	15.31	7.21	1.58	0.35	0.26	0.09	0.44
Skeletal Muscle Cells, donor2	11358-117H8	37.59	47.71	7.95	2.89	0.72	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	143.80	176.40	51.83	10.87	3.34	2.51	1.67	4.18	0.84
Skeletal Muscle Cells, donor4	11451-119A2	131.17	81.22	35.19	8.01	1.10	0.79	1.26	0.31	0.16
Skeletal Muscle Cells, donor5	11455-119A6	117.58	77.30	33.30	6.39	1.19	0.30	0.45	0.15	0.15
Skeletal Muscle Cells, donor6	11459-119B1	77.72	93.42	32.32	4.92	1.23	0.77	0.77	0.46	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	102.44	54.94	23.31	5.80	1.51	0.63	0.25	0.38	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	86.18	60.50	28.82	6.14	2.00	0.71	0.57	0.43	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	113.00	80.76	42.76	8.53	1.79	0.89	0.99	0.40	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	76.08	48.87	15.92	7.92	1.69	0.42	0.67	0.08	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	167.91	99.16	45.60	11.58	2.17	2.17	1.45	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	146.13	92.60	36.88	8.67	3.99	1.79	1.24	1.24	0.28
Skin - palm, donor1	10286-104F7	45.66	29.55	10.74	0.00	0.00	0.00	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	54.20	39.93	23.79	2.02	0.72	0.00	0.14	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	66.25	78.52	37.62	0.82	1.64	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	53.75	37.65	20.38	2.34	0.39	0.00	0.00	0.13	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	86.46	34.61	19.60	5.84	0.28	0.14	0.14	0.14	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	73.14	51.90	17.44	4.92	0.56	0.14	0.14	0.42	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	119.26	61.11	42.50	5.71	0.85	0.00	0.42	0.00	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	66.86	32.30	13.94	4.42	0.45	0.07	0.07	0.00	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	104.30	99.98	25.00	9.87	5.25	3.09	4.32	2.78	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	85.38	109.39	18.68	5.78	2.22	2.00	3.78	1.78	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	187.52	132.26	32.92	15.28	5.88	5.88	1.76	2.35	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	217.01	72.26	26.08	11.71	5.30	7.96	6.41	5.08	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	318.57	132.70	44.50	18.11	7.09	13.39	10.63	3.15	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	161.47	141.38	30.13	20.86	7.73	8.50	4.64	2.32	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	34.03	22.02	8.01	4.00	0.00	0.00	3.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	224.50	126.82	33.67	16.90	8.38	9.85	6.79	2.93	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	157.82	56.30	22.17	4.21	6.87	3.10	4.65	3.99	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	186.92	151.59	43.91	15.24	7.81	16.26	6.91	5.51	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	186.56	72.61	36.79	11.72	3.26	2.28	4.56	4.88	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	216.47	92.73	41.94	15.65	6.50	6.50	6.79	8.27	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	180.80	87.41	29.33	8.97	4.98	5.84	3.70	4.84	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	116.96	94.84	34.16	7.48	2.44	1.30	1.95	1.14	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	67.89	38.66	7.31	1.83	1.52	0.61	1.52	0.61	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	167.45	82.84	25.76	10.10	2.78	0.76	2.53	0.76	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	79.57	61.21	36.72	6.12	0.00	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	220.78	144.48	30.04	12.87	3.81	5.72	4.29	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	81.41	82.59	18.73	6.34	2.80	0.59	1.47	0.44	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	82.22	74.26	15.93	5.81	1.29	1.51	0.65	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	108.84	78.51	24.67	5.77	1.68	0.94	1.05	0.31	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	330.86	144.16	47.95	17.01	11.14	16.40	15.47	6.03	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	328.75	118.57	67.91	16.17	11.86	18.32	12.93	6.47	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	178.72	116.55	26.00	7.47	4.48	4.48	2.99	2.09	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	146.46	99.35	34.48	8.88	1.71	2.39	1.37	1.02	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	75.47	39.89	12.88	6.44	0.79	0.24	0.24	0.31	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	117.55	68.13	31.80	8.35	3.82	4.03	2.01	1.31	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	138.12	63.94	18.43	4.32	2.96	4.10	4.78	1.59	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	251.79	162.43	42.27	9.06	4.23	7.25	5.43	3.62	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	102.00	75.24	40.53	8.48	1.59	0.79	1.06	0.26	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	134.36	98.94	18.64	6.13	4.53	2.53	1.20	0.93	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	111.32	60.36	18.66	3.88	2.88	2.13	2.00	0.63	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	92.08	35.26	8.12	4.31	3.55	1.27	2.03	1.27	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	213.80	97.55	34.07	9.95	4.52	5.28	5.13	3.77	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	111.77	67.52	19.50	5.25	3.75	3.00	1.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	585.37	62.03	19.38	14.21	3.88	0.00	5.17	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	155.33	97.20	40.93	14.42	2.79	5.12	1.86	1.40	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	199.93	69.67	35.85	5.55	6.56	7.07	7.07	5.55	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	214.99	101.54	34.16	11.60	6.27	10.34	8.46	8.15	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	108.56	53.69	17.99	5.31	2.36	1.77	1.47	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	152.70	57.23	28.91	5.58	1.17	1.33	0.75	0.25	0.67
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	86.89	37.37	14.48	2.80	1.87	0.47	1.40	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	326.41	146.36	43.32	23.60	10.79	14.68	7.48	2.16	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	382.43	142.01	51.76	12.24	14.02	21.67	11.98	5.10	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	300.48	154.56	44.94	12.97	8.46	11.66	3.76	3.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	132.06	60.23	27.53	5.87	2.24	1.54	1.40	0.70	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	185.26	84.21	26.39	10.31	3.60	3.60	3.10	1.09	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	38.09	30.48	10.00	5.71	0.00	0.00	0.48	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	316.84	158.54	43.06	17.86	11.99	13.46	6.85	3.18	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	195.76	126.60	34.47	10.61	3.98	6.85	3.54	5.74	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	67.59	60.27	19.60	6.73	1.17	0.59	0.29	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	32.26	31.68	7.19	0.97	0.78	0.39	0.19	0.19	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	126.41	69.02	12.69	4.50	1.85	2.38	1.32	0.79	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	31.62	30.50	4.46	0.00	0.37	0.37	0.74	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	144.09	62.17	16.53	3.59	4.31	6.11	5.75	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	60.75	86.02	21.86	3.12	2.27	1.70	1.99	0.85	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	142.97	89.41	27.96	9.06	3.94	2.36	2.76	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	54.09	36.32	8.38	0.76	0.76	0.51	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	36.34	47.12	6.39	3.19	0.00	0.40	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	68.97	39.71	10.87	3.34	1.67	0.42	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	38.04	37.13	8.71	1.38	1.83	0.46	0.00	0.46	0.00
Synoviocyte, donor1	11291-117A4	225.89	111.93	29.96	16.50	7.07	7.41	8.75	5.22	0.00
Synoviocyte, donor2	11368-117I9	66.38	32.35	9.22	1.17	3.02	1.34	2.51	2.18	0.00
Synoviocyte, donor3	11440-118H9	61.66	40.44	4.47	2.01	0.89	1.79	2.01	1.56	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	155.44	138.29	55.74	11.08	4.29	2.50	0.71	1.07	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	65.41	63.43	29.73	1.98	0.00	0.00	3.96	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	139.62	88.45	35.89	8.10	3.24	2.32	0.69	0.46	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	100.86	47.60	30.75	6.16	0.50	0.07	0.14	0.07	0.79
Tracheal Epithelial Cells, donor2	11369-118A1	85.04	40.59	25.51	5.80	0.39	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	83.61	61.27	22.33	4.58	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	54.13	38.01	9.72	4.55	0.25	0.25	0.86	0.86	0.49
Urethra, donor2	10319-105A4	48.56	55.75	14.39	0.00	1.80	0.00	0.00	1.80	1.80
Urothelial Cells, donor1	11520-119H8	83.15	72.26	64.29	10.63	0.80	0.27	0.27	0.53	1.06
Urothelial Cells, donor2	11600-120H7	87.32	46.47	30.04	6.41	0.80	0.80	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	58.68	48.82	47.22	7.11	0.00	0.00	0.00	0.00	0.46
Urothelial cells, donor0	11216-116B1	81.80	58.62	52.60	9.36	0.00	0.00	0.00	0.00	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	133.47	164.61	100.55	12.46	0.89	0.89	0.89	0.89	6.23
Whole blood (ribopure), donor090309, donation2	12180-129A2	142.96	131.52	108.65	7.15	0.00	0.00	0.00	0.00	7.15
Whole blood (ribopure), donor090309, donation3	12181-129A3	137.59	62.29	85.56	4.79	1.37	0.00	0.00	0.68	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	102.27	67.15	83.33	12.40	1.03	0.69	0.00	0.34	2.41
Whole blood (ribopure), donor090325, donation2	12177-128I8	100.52	56.36	79.02	9.30	0.00	0.58	0.00	0.58	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	132.24	125.99	88.51	4.16	4.16	0.00	0.00	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	113.81	121.15	100.96	10.10	1.84	0.00	0.00	0.00	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	110.46	54.77	73.94	5.48	0.00	1.83	0.91	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	53.05	69.21	30.72	8.14	0.99	0.99	0.86	0.49	0.49
Wilms' tumor cell line:HFWT	10597-108E3	33.44	44.00	12.32	4.40	3.52	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	28.21	18.16	9.50	0.56	0.00	0.00	0.00	0.00	0.84
achilles tendon, donor2	10292-104G4	59.93	43.40	8.27	0.00	0.00	0.00	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	36.71	28.30	20.40	2.55	0.25	0.00	0.00	0.00	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	40.63	39.01	78.48	6.04	0.00	0.00	0.00	0.00	3.25
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	55.67	68.02	108.97	11.87	0.24	0.12	0.12	0.00	1.07
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	77.28	66.40	324.09	20.14	0.82	0.00	0.00	0.00	7.07
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	30.08	30.92	16.30	2.81	0.00	0.00	0.00	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	81.63	71.69	54.56	11.63	0.00	0.00	0.00	0.21	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	53.35	45.46	30.76	10.89	0.00	0.27	0.00	0.00	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	21.59	26.88	28.20	5.73	0.00	0.00	0.00	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	47.78	37.98	49.00	5.72	0.00	0.00	0.41	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	28.35	38.05	34.17	4.66	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	39.01	39.38	35.14	6.62	0.37	0.00	0.18	0.55	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	74.11	74.11	70.21	11.70	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	66.93	47.17	39.50	5.81	0.46	0.70	0.70	0.00	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	63.69	67.83	66.54	6.99	0.26	0.26	0.00	0.00	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	79.78	95.86	60.20	12.27	0.00	0.29	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	61.35	43.69	17.20	2.79	0.00	0.00	0.00	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	37.84	65.80	19.74	5.35	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	37.45	101.29	11.36	9.21	0.31	0.31	1.23	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	87.90	83.21	23.47	10.67	0.43	0.00	1.28	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	88.87	80.37	25.17	7.28	0.61	0.61	0.30	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	80.88	80.88	24.55	13.24	0.48	0.24	0.48	0.24	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	39.87	50.12	28.29	4.23	0.00	0.00	0.00	0.45	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	66.04	47.70	28.35	6.34	0.00	0.33	0.33	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	27.87	72.47	31.59	1.86	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	84.37	51.98	47.08	5.27	0.38	0.38	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	61.49	71.96	36.64	4.36	0.44	0.00	0.00	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	56.23	84.35	20.62	7.50	1.87	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	58.64	56.99	9.42	1.88	0.24	0.24	0.00	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	61.27	37.54	14.27	2.64	0.47	0.31	0.47	0.78	0.31
adipose, donor1	10184-103D4	54.54	83.86	72.13	7.04	0.00	0.00	0.00	0.59	0.00
adipose, donor2	10185-103D5	21.09	35.69	45.01	6.89	0.81	0.00	0.41	0.81	0.41
adipose, donor3	10186-103D6	37.85	63.17	53.10	8.17	0.82	0.00	0.00	0.00	0.27
adipose, donor4	10187-103D7	25.14	64.14	97.08	15.60	0.00	0.00	0.00	0.00	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	12.15	23.52	31.88	4.10	0.16	0.00	0.16	0.16	0.63
adrenal gland, adult, pool1	10081-102A9	25.46	25.46	10.91	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	71.91	80.18	21.75	6.27	0.13	0.00	0.27	0.00	0.93
alveolar cell carcinoma cell line:SW 1573	10708-109H6	41.45	40.37	10.00	2.86	0.36	0.36	0.00	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	43.82	26.20	8.58	1.16	0.70	0.23	0.00	0.23	1.39
amniotic membrane cells, donor2	12236-129G4	32.46	26.71	11.83	1.35	1.01	0.00	0.00	0.00	0.68
amniotic membrane cells, donor3	12237-129G5	32.41	16.50	11.19	0.59	0.29	0.29	0.59	0.00	1.47
amygdala - adult, donor10196	10167-103B5	15.42	17.79	32.02	0.00	0.00	0.00	0.00	1.19	4.74
amygdala, adult, donor10252	10151-102I7	14.80	19.26	30.42	1.22	0.00	0.41	0.00	0.41	1.22
amygdala, newborn, donor10223	10360-105E9	24.53	18.40	43.90	2.58	0.32	0.00	0.32	0.32	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	121.60	78.18	33.74	14.13	1.02	1.02	0.51	0.25	1.27
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	70.38	74.35	21.18	6.62	0.22	0.00	0.00	0.00	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	19.37	70.48	23.05	5.68	0.33	0.33	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	104.54	69.23	24.91	4.90	2.55	1.18	0.39	0.20	0.59
appendix, adult	10189-103D9	71.03	56.28	50.07	13.20	1.16	0.00	0.78	0.39	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	22.36	35.08	24.08	7.22	0.34	0.34	0.00	0.00	0.69
artery, adult	10190-103E1	31.25	50.27	23.10	4.08	0.00	0.00	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	73.88	151.82	37.38	19.70	2.61	0.58	0.29	0.29	0.14
b cell line:RPMI1788	10427-106D4	36.13	42.97	26.47	9.37	0.15	0.00	0.00	0.30	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	273.01	123.19	28.58	9.99	8.05	7.77	10.27	3.05	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	56.86	49.81	12.90	4.37	0.99	0.30	0.10	0.50	0.79
bile duct carcinoma cell line:TFK-1	10496-107C1	43.18	38.16	9.71	2.34	0.00	0.00	0.00	0.17	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	49.77	41.94	16.78	8.95	0.00	0.00	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	85.50	81.15	29.88	7.39	1.09	0.54	0.76	0.43	0.43
blood, adult, pool1	10053-101G8	62.01	50.94	62.01	8.86	0.00	0.00	0.00	2.21	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	146.44	83.07	11.99	5.14	8.56	6.85	7.71	5.14	0.00
bone marrow, adult	10192-103E3	66.81	35.09	13.50	5.40	1.35	0.67	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	3.08	19.48	20.50	2.05	2.05	0.00	0.00	0.00	2.05
brain, adult, pool1	10012-101C3	15.92	19.71	26.61	2.45	0.00	0.00	0.00	0.22	2.34
brain, fetal, pool1	10085-102B4	13.36	10.69	112.20	5.34	0.00	0.00	0.00	0.00	8.01
breast carcinoma cell line:MCF7	10482-107A5	43.28	39.97	31.71	6.28	0.00	0.33	0.33	0.00	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	28.46	37.82	19.22	3.37	0.00	0.00	0.00	0.00	0.87
breast, adult, donor1	10080-102A8	33.46	42.93	5.68	1.26	1.26	0.00	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	16.90	10.04	9.53	0.64	0.13	0.13	0.13	0.25	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	91.84	98.64	25.67	8.66	0.00	0.00	0.31	0.00	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	30.39	31.08	28.32	2.30	1.38	0.23	0.23	0.00	2.76
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	34.38	33.89	8.47	2.42	0.73	0.00	0.00	0.24	1.69
carcinoid cell line:NCI-H1770	10703-109H1	1.88	19.75	5.64	1.41	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	59.50	48.67	24.39	3.83	0.66	0.00	0.00	0.22	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	1.27	8.87	30.74	0.95	0.00	0.00	0.00	0.00	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	39.13	59.89	18.90	7.72	1.33	0.27	0.27	0.27	0.80
caudate nucleus - adult, donor10196	10177-103C6	20.72	29.93	29.93	0.00	1.15	0.00	0.00	1.15	2.30
caudate nucleus, adult, donor10252	10164-103B2	18.24	18.57	17.40	1.51	0.17	0.00	0.17	0.33	0.67
caudate nucleus, adult, donor10258	10379-105H1	9.93	23.69	12.99	0.00	0.00	0.00	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	17.58	30.76	26.37	5.49	0.00	0.00	0.00	0.00	0.73
cerebellum - adult, donor10196	10173-103C2	5.83	17.48	8.74	2.91	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	9.61	13.45	12.60	1.92	0.43	0.00	0.21	0.21	1.71
cerebellum, adult, pool1	10083-102B2	6.21	11.38	13.11	0.00	0.00	0.00	0.00	0.00	1.72
cerebellum, newborn, donor10223	10357-105E6	15.78	8.30	28.23	0.83	0.00	0.00	0.00	0.00	1.66
cerebral meninges, adult	10188-103D8	32.78	21.68	29.75	1.51	0.50	0.00	0.00	0.00	0.50
cerebrospinal fluid, donor2	10294-104G6	27.77	18.27	10.23	2.19	0.00	0.00	0.00	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	17.97	15.38	7.33	3.16	0.00	0.00	0.00	0.00	0.58
cervical cancer cell line:ME-180	10553-107I4	109.70	49.88	27.51	4.81	0.99	0.00	0.50	0.17	0.83
cervix, adult, pool1	10013-101C4	95.12	70.55	30.66	7.24	1.57	1.05	0.84	0.73	0.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	120.95	103.53	38.60	10.17	2.09	1.11	0.98	0.28	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	71.84	117.56	14.37	2.61	0.00	1.31	2.61	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	33.31	45.24	31.44	10.81	0.00	0.12	0.00	0.12	0.50
choriocarcinoma cell line:SCH	10785-110H2	28.83	64.81	35.49	5.79	0.00	0.00	0.00	0.00	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	12.57	33.68	16.13	4.03	0.00	0.00	0.00	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	33.34	43.31	10.54	2.85	0.28	0.00	0.00	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	149.25	106.29	21.58	7.46	3.08	1.49	1.79	0.70	0.10
chorionic membrane cells, donor3	12240-129G8	56.60	48.90	13.19	4.40	0.00	0.00	0.00	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	58.57	22.22	128.24	2.02	2.02	0.00	0.00	0.00	7.07
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	128.90	79.53	48.41	9.99	0.96	0.96	0.38	0.19	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	68.21	55.54	17.74	4.86	0.63	0.21	0.21	0.21	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	25.68	26.71	27.22	2.31	0.00	0.00	0.00	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	31.93	24.91	24.67	2.18	0.00	0.00	0.00	0.00	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	33.60	26.67	25.86	3.26	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	52.41	48.88	25.03	5.59	0.29	0.00	0.00	0.00	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	63.59	40.92	29.45	5.47	0.78	0.00	0.26	0.26	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	21.03	57.60	25.14	5.26	0.91	0.00	0.00	0.00	1.60
clear cell carcinoma cell line:TEN	10636-108I6	59.69	39.56	13.01	5.21	0.35	0.35	0.52	0.17	0.69
colon carcinoma cell line:CACO-2	10513-107D9	62.23	56.93	22.33	5.86	0.55	0.00	0.00	0.18	0.73
colon carcinoma cell line:COLO-320	10420-106C6	25.85	38.39	26.61	6.84	0.00	0.00	0.00	0.00	1.90
colon, adult, donor1	10082-102B1	109.48	61.88	30.94	4.76	1.19	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	77.20	60.75	20.33	4.47	0.35	0.12	0.12	0.12	0.71
colon, fetal, donor1	10070-101I7	58.71	48.20	21.01	2.47	0.00	1.24	0.62	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	82.50	73.34	114.59	9.17	0.00	0.00	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	25.04	0.00	0.00	0.00	0.00	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	82.86	43.34	21.67	6.37	0.00	0.00	0.00	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	113.65	43.17	18.56	6.64	0.60	0.00	0.15	0.00	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	121.69	53.30	19.46	9.73	0.28	0.42	0.14	0.28	0.14
corpus callosum, adult, pool1	10042-101F6	30.29	40.47	37.70	4.42	0.77	0.00	0.11	0.22	2.10
cruciate ligament, donor2	10295-104G7	78.62	37.28	12.97	0.00	0.81	1.62	1.62	2.43	0.81
diaphragm, fetal, donor1	10069-101I6	29.69	37.72	20.87	6.42	0.00	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	11.28	17.28	13.44	1.20	0.24	0.00	0.00	0.00	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	41.56	33.52	28.93	5.74	0.00	0.00	0.00	0.23	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	41.80	28.98	16.67	4.62	0.26	0.00	0.00	0.00	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	37.55	30.81	16.85	1.93	0.24	0.00	0.00	0.00	0.00
ductus deferens, adult	10196-103E7	55.81	45.85	17.94	3.99	1.50	1.50	0.00	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	46.09	43.21	25.92	2.88	1.44	0.00	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	52.97	50.02	38.99	1.47	0.00	0.00	0.74	0.00	0.00
dura mater, adult, donor1	10041-101F5	97.37	53.02	14.54	3.88	0.99	0.08	0.33	0.74	0.50
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	24.65	26.20	19.54	6.22	0.00	0.00	0.00	0.44	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	27.94	18.91	27.80	4.59	0.00	0.14	0.00	0.00	1.43
embryonic pancreas cell line:1B2C6	10604-108F1	54.26	56.73	10.48	4.93	1.23	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	45.10	49.64	11.81	3.33	0.30	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	59.28	66.69	14.51	2.47	2.16	0.93	0.31	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	51.23	53.85	13.13	1.31	1.31	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	21.12	28.16	9.39	4.69	0.00	0.00	0.34	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	40.05	67.60	21.75	8.70	1.63	0.00	0.18	0.18	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	98.26	88.13	38.11	9.97	0.32	0.16	0.00	0.00	0.80
epidermoid carcinoma cell line:A431	10426-106D3	39.68	16.23	9.67	1.67	0.00	0.11	0.22	0.33	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	54.33	42.56	16.83	4.95	0.66	0.11	0.00	0.33	0.66
epididymis, adult	10197-103E8	93.14	55.26	24.28	7.12	1.05	0.00	0.21	1.26	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	62.27	73.98	27.32	5.85	3.90	1.60	1.06	0.00	1.60
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	30.28	30.67	10.62	3.93	0.39	0.79	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	26.47	26.08	9.30	4.32	0.13	0.13	0.52	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	23.13	20.18	5.31	2.56	0.10	0.10	0.00	0.10	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	30.47	21.40	8.07	3.70	0.56	0.34	0.34	0.00	0.22
esophagus, adult, pool1	10015-101C6	87.38	55.96	21.98	4.03	1.06	0.21	0.42	1.06	1.06
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	64.00	39.45	19.79	4.38	0.00	0.13	0.00	0.25	0.25
eye - muscle inferior rectus, donor1	10272-104E2	16.90	7.24	2.41	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	29.46	16.83	10.52	2.10	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	20.84	25.30	8.93	1.49	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	22.93	19.49	9.17	1.15	0.00	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	48.09	29.15	30.61	2.91	2.91	0.00	0.00	1.46	1.46
eye, fetal, donor1	10054-101G9	45.00	43.73	34.32	3.31	0.25	0.00	0.00	1.02	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	83.22	74.24	20.13	5.00	1.54	0.26	0.13	0.00	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	32.76	35.61	14.01	3.80	0.47	0.00	0.47	0.24	0.47
frontal lobe, adult, pool1	10040-101F4	11.07	11.82	32.74	1.69	0.19	0.00	0.00	0.00	2.63
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	137.51	111.69	51.64	13.21	0.00	0.00	0.00	0.00	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	20.85	22.58	6.03	1.37	0.37	0.00	0.09	0.27	0.37
gall bladder, adult	10198-103E9	91.02	55.29	26.56	4.35	1.69	0.72	0.24	0.48	0.24
gamma delta positive T cells, donor1	11937-126A2	95.02	83.75	109.52	9.66	0.54	0.00	1.07	0.54	1.07
gamma delta positive T cells, donor2	11938-126A3	116.53	88.52	55.28	9.34	1.49	0.00	0.00	0.00	1.87
gastric adenocarcinoma cell line:MKN1	10614-108G2	49.00	48.79	17.32	4.65	0.63	0.00	0.00	0.21	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	25.53	25.53	7.74	1.55	0.19	0.00	0.00	0.00	0.39
gastric cancer cell line:AZ521	10549-107H9	26.72	48.20	20.99	9.51	0.98	0.00	0.00	0.33	1.48
gastric cancer cell line:GSS	10560-108A2	4.58	16.47	10.98	0.92	0.00	0.00	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	6.40	7.31	5.48	0.91	0.00	0.00	0.00	0.00	0.23
giant cell carcinoma cell line:LU65	10487-107B1	22.72	19.16	10.44	2.98	0.00	0.00	0.00	0.00	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	47.87	32.19	16.10	3.50	0.56	0.28	0.14	0.28	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	20.45	18.96	4.24	1.25	0.00	0.00	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	59.74	66.29	19.42	6.86	1.58	1.37	0.95	0.53	0.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	63.34	68.53	21.63	5.62	2.39	0.98	1.83	0.84	0.98
glioblastoma cell line:T98G	10485-107A8	49.01	41.28	7.06	2.76	1.32	1.32	0.77	0.44	0.55
glioma cell line:GI-1	10413-106B8	33.97	46.57	10.25	5.86	0.00	0.59	0.00	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	21.87	36.45	16.76	2.92	0.73	0.73	1.46	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	29.54	31.98	27.34	1.95	0.73	0.49	0.73	0.00	2.20
globus pallidus, adult, donor10258	10367-105F7	17.80	31.49	13.69	1.37	0.00	0.00	1.37	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	28.24	29.31	23.98	2.66	0.53	0.00	1.60	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	66.07	95.44	68.52	12.24	7.34	2.45	0.00	0.00	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	21.86	32.79	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	47.04	10.45	10.45	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	88.00	102.40	29.12	9.92	3.84	0.64	2.24	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	17.45	67.95	90.90	4.13	0.92	0.00	0.00	0.46	1.38
hIPS +CCl2, biol_rep2	14384-156C1	18.29	56.70	89.17	3.20	1.37	0.00	0.00	0.00	1.83
hIPS +CCl2, biol_rep3	14385-156C2	23.19	86.95	125.60	4.51	1.29	0.00	0.64	0.00	1.29
hIPS, biol_rep1	14380-156B6	17.25	54.62	97.74	1.44	0.00	0.00	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	14.40	66.53	98.76	1.37	0.69	0.69	0.00	0.69	0.69
hIPS, biol_rep3	14382-156B8	8.83	40.83	39.72	2.21	0.00	0.00	0.00	0.00	3.31
hairy cell leukemia cell line:Mo	10712-109I1	117.52	66.09	44.25	8.62	0.00	0.00	0.00	0.57	0.29
heart - mitral valve, adult	10205-103F7	31.09	32.59	14.35	3.29	0.60	0.00	0.00	2.09	0.30
heart - pulmonic valve, adult	10206-103F8	43.67	42.10	20.66	3.66	1.31	0.78	0.00	0.26	0.26
heart - tricuspid valve, adult	10207-103F9	49.96	34.14	9.99	3.33	0.00	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	43.67	53.05	19.39	5.10	0.20	0.20	0.00	0.41	0.61
heart, adult, diseased, donor1	10051-101G6	37.90	57.91	25.55	6.81	0.00	0.43	0.00	0.43	0.43
heart, adult, pool1	10016-101C7	57.95	64.85	21.39	6.21	0.69	0.46	0.23	1.15	0.69
heart, fetal, pool1	10046-101G1	60.17	76.50	39.33	11.71	0.10	0.21	0.31	0.92	0.82
hepatic mesenchymal tumor cell line:LI90	10778-110G4	211.65	135.13	29.62	9.87	6.17	4.94	3.39	1.23	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	26.16	19.03	17.84	1.19	0.00	0.00	0.00	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	40.55	61.77	23.98	4.97	1.10	0.44	0.66	0.11	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	48.79	66.27	25.85	4.01	0.73	0.36	1.21	0.12	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	40.93	67.10	26.48	5.66	1.41	0.81	0.71	0.20	0.61
hepatoma cell line:Li-7	10484-107A7	55.39	64.51	12.34	3.45	0.67	0.00	0.00	0.22	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	59.70	89.55	34.67	10.15	0.10	0.00	0.00	0.20	0.20
hippocampus - adult, donor10196	10169-103B7	13.25	14.19	50.16	0.95	1.89	0.00	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	20.41	24.49	23.88	1.22	0.41	0.00	0.20	0.00	2.04
hippocampus, adult, donor10258	10374-105G5	4.48	13.44	16.93	2.49	0.50	0.00	0.00	1.00	0.50
hippocampus, newborn, donor10223	10363-105F3	23.62	21.15	57.10	3.88	0.70	0.35	0.35	0.35	2.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	42.72	69.58	166.62	15.26	0.00	0.61	0.00	0.00	4.27
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	34.75	45.36	128.02	11.39	0.20	0.20	0.00	0.20	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	35.80	62.97	154.11	12.95	0.51	0.00	0.00	0.00	1.27
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	29.32	59.21	47.93	3.95	1.69	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	31.50	40.02	63.52	6.20	0.00	0.00	0.26	0.00	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	24.67	54.66	59.22	4.93	0.00	0.00	0.00	0.38	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	40.00	68.32	53.43	9.63	0.58	0.00	0.29	0.00	2.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	29.30	44.81	62.91	7.32	0.22	0.00	0.00	0.00	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	44.63	63.40	53.39	11.26	0.42	0.00	0.00	0.00	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	45.70	50.91	42.15	7.58	0.00	0.00	0.00	0.00	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	48.54	62.04	43.88	10.93	0.16	0.64	0.00	0.00	1.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	45.78	56.56	55.21	10.10	0.67	0.00	0.00	0.00	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	31.45	52.89	103.59	12.83	0.63	0.16	0.00	0.00	1.56
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	32.43	47.16	109.07	11.79	0.00	0.98	0.49	0.98	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	34.91	37.53	97.75	13.96	0.00	0.00	0.00	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	34.55	52.50	48.11	9.16	0.76	0.19	0.00	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	30.96	47.53	40.99	9.16	0.00	0.00	0.00	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	37.98	64.97	49.98	8.00	0.00	0.00	0.50	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	21.48	33.35	47.85	5.84	0.19	0.38	0.00	0.00	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	19.55	25.46	48.65	3.64	0.00	0.45	0.00	0.00	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	21.30	41.97	50.74	9.40	0.00	0.31	0.00	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	38.87	45.56	41.97	7.51	0.00	0.16	0.00	0.16	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	38.03	51.68	42.09	6.10	0.29	0.00	0.00	0.00	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	40.35	70.84	50.82	3.29	1.49	0.00	0.00	0.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	35.47	58.56	119.71	10.35	0.55	0.74	0.00	0.37	1.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	30.53	68.47	125.24	11.70	0.57	0.00	0.00	0.29	2.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	45.32	111.88	158.02	11.84	0.41	0.82	0.00	0.00	3.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	42.95	61.61	54.57	6.69	0.00	0.00	0.00	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	26.92	54.80	63.66	7.92	0.63	0.32	0.00	0.00	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	36.01	66.88	62.64	8.78	0.91	0.30	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	19.65	41.37	40.85	5.17	0.00	0.00	0.00	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	14.61	39.19	39.19	7.31	1.33	0.00	0.00	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	24.63	56.44	32.07	4.87	1.28	0.00	0.00	0.00	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	43.20	54.20	40.14	6.39	0.51	0.51	0.26	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	31.05	43.16	46.95	6.06	0.76	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	54.78	82.00	37.30	9.41	0.34	0.34	0.00	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	23.67	61.58	112.30	8.94	0.48	0.00	0.00	0.24	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	33.87	69.08	106.07	11.14	0.00	0.45	0.00	0.00	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	34.15	85.37	131.71	11.71	0.49	0.00	0.00	0.00	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	23.53	45.84	67.24	7.64	0.31	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	78.08	84.58	133.38	13.01	3.25	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	32.43	66.19	69.17	8.94	0.00	0.00	0.33	0.66	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	15.32	52.54	61.30	7.11	0.55	0.00	0.00	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	19.18	43.79	49.58	9.41	0.00	0.00	0.00	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	21.71	46.98	46.62	5.69	0.00	0.36	0.00	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	26.25	40.58	34.61	8.35	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	44.15	68.93	52.00	10.29	0.41	0.00	0.14	0.14	0.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	40.95	83.24	49.84	9.16	0.27	0.00	0.27	0.27	0.00
immature langerhans cells, donor1	11904-125F5	140.93	81.60	23.49	4.12	1.45	0.24	0.00	0.73	1.21
immature langerhans cells, donor2	11905-125F6	101.39	67.33	59.41	4.75	0.00	0.00	0.79	0.00	3.17
insula, adult, pool1	10039-101F3	13.91	14.67	46.94	3.12	0.38	0.19	0.09	0.47	2.37
keratoacanthoma cell line:HKA-1	10791-110H8	27.96	22.76	7.80	0.98	0.33	0.00	0.00	0.33	0.33
kidney, adult, pool1	10017-101C8	79.90	66.99	25.23	4.51	1.10	0.80	0.90	0.50	0.80
kidney, fetal, pool1	10045-101F9	49.44	44.99	29.85	5.94	0.28	0.21	0.14	0.14	1.84
large cell lung carcinoma cell line:IA-LM	10509-107D5	31.39	24.14	15.48	5.68	1.28	0.28	0.28	0.14	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	19.77	17.83	6.08	0.69	0.14	0.00	0.14	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	38.17	42.76	15.05	6.42	0.92	0.18	0.00	0.18	0.00
left atrium, adult, donor1	10079-102A7	33.78	53.94	16.35	2.72	0.00	0.54	0.54	0.00	0.54
left ventricle, adult, donor1	10078-102A6	30.84	39.95	12.64	1.52	0.00	0.00	0.00	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	82.08	71.14	26.27	6.57	2.74	1.37	1.64	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	121.07	54.97	24.43	6.11	1.80	2.16	0.72	0.72	0.36
leiomyoma cell line:15242A	10570-108B3	160.33	83.15	24.46	9.24	5.43	7.07	9.24	1.63	0.00
leiomyoma cell line:15425	10571-108B4	166.09	61.19	27.92	8.26	5.10	5.10	2.43	1.21	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	152.38	69.84	44.45	12.70	0.00	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	24.05	43.91	16.73	2.09	4.18	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	100.23	74.38	49.70	9.09	1.18	0.59	0.35	0.24	0.71
liposarcoma cell line:KMLS-1	10782-110G8	105.13	85.76	23.59	7.03	3.59	5.47	3.59	0.94	0.31
liposarcoma cell line:SW 872	10726-110A6	46.06	53.12	9.38	3.17	0.97	1.10	1.95	0.49	0.12
liver, adult, pool1	10018-101C9	43.43	45.86	9.24	2.59	0.49	0.00	0.16	0.16	0.97
liver, fetal, pool1	10086-102B5	38.57	28.22	7.53	1.88	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	17.94	17.50	19.83	2.19	0.15	0.29	1.02	1.31	1.60
locus coeruleus, adult, donor10252	10165-103B3	20.30	25.10	22.88	2.40	0.74	0.00	0.37	0.37	1.11
locus coeruleus, adult, donor10258	10375-105G6	18.62	30.19	29.91	2.82	0.28	0.00	0.00	0.00	1.41
locus coeruleus, newborn, donor10223	10362-105F2	34.07	31.13	19.35	2.10	0.00	0.00	0.00	1.68	1.26
lung adenocarcinoma cell line:A549	10499-107C4	30.03	50.10	11.35	6.50	0.69	0.28	0.00	0.28	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	46.88	38.61	11.03	6.20	0.00	0.00	0.00	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	71.97	69.73	13.71	2.24	1.19	0.13	0.13	0.00	0.13
lung, adult, pool1	10019-101D1	64.62	46.42	18.66	4.61	0.95	0.47	0.83	0.71	0.83
lung, fetal, donor1	10068-101I5	52.51	81.06	37.67	3.14	0.57	0.29	1.14	0.57	2.28
lung, right lower lobe, adult, donor1	10075-102A3	38.95	54.99	18.33	3.21	1.37	0.00	0.46	0.46	0.00
lymph node, adult, donor1	10077-102A5	51.60	49.23	31.72	5.68	0.95	0.00	0.00	0.47	0.95
lymphangiectasia cell line:DS-1	10727-110A7	91.40	123.84	35.29	13.59	0.22	0.22	0.00	0.00	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	16.60	20.38	13.28	4.53	0.00	0.00	0.00	0.15	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	54.37	23.79	17.84	5.10	0.00	0.85	0.00	0.00	0.85
mature adipocyte, donor1	12231-129F8	21.31	35.08	7.99	1.78	0.00	0.00	0.00	0.00	0.44
mature adipocyte, donor2	12232-129F9	23.87	31.96	4.98	1.45	0.21	0.00	0.00	0.00	0.21
mature adipocyte, donor3	12233-129G1	23.71	33.90	3.79	1.42	0.00	0.00	0.00	0.00	0.24
mature adipocyte, donor4	12234-129G2	22.90	33.17	4.74	2.37	0.00	0.00	0.00	0.00	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	21.44	24.78	17.15	3.57	0.24	0.00	0.00	0.00	2.38
medial frontal gyrus - adult, donor10196	10170-103B8	9.02	14.66	27.07	0.00	0.00	0.00	0.00	3.38	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	13.61	13.61	18.76	1.10	0.00	0.18	0.37	0.18	2.21
medial frontal gyrus, adult, donor10258	10368-105F8	5.72	10.80	21.29	1.27	0.32	0.00	0.00	0.32	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	22.60	24.74	62.69	1.71	0.43	0.00	0.00	0.00	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	10.13	13.50	31.89	0.68	0.17	0.00	0.00	0.34	1.01
medial temporal gyrus, adult, donor10252	10156-103A3	17.19	18.04	16.77	1.49	0.21	0.00	0.00	0.00	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	0.00	7.71	34.67	0.00	0.00	0.00	0.00	0.00	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	28.71	14.35	14.35	0.00	0.00	0.00	0.00	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	16.15	12.92	69.27	1.08	1.08	0.00	0.00	0.72	1.08
medulla oblongata - adult, donor10196	10174-103C3	48.02	36.34	33.75	3.24	1.30	0.00	0.65	1.30	2.60
medulla oblongata, adult, donor10252	10155-103A2	26.94	32.35	23.84	4.49	0.62	0.15	0.00	0.00	2.01
medulla oblongata, adult, pool1	10038-101F2	31.75	30.77	28.98	4.41	0.57	0.16	0.08	0.49	2.37
medulla oblongata, newborn, donor10223	10361-105F1	23.61	31.94	24.30	4.17	0.00	0.00	0.00	0.35	2.43
medulloblastoma cell line:D283 Med	10838-111E1	28.78	24.13	51.15	6.42	0.22	0.00	0.00	0.22	3.32
medulloblastoma cell line:ONS-76	10759-110E3	34.97	46.59	20.30	4.77	0.61	0.12	0.12	0.12	0.12
melanoma cell line:COLO 679	10514-107E1	62.39	47.87	21.13	5.89	1.44	0.29	0.29	0.14	1.01
melanoma cell line:G-361	10465-106H6	26.06	20.63	5.43	2.17	0.00	0.00	0.27	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	81.05	58.97	12.30	2.71	0.90	0.72	0.36	0.72	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	13.22	32.60	36.13	2.64	0.00	0.00	0.00	0.88	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	12.96	23.59	37.07	3.63	0.00	0.00	0.26	0.00	3.37
mesenchymal precursor cell - adipose, donor1	11747-123G1	102.34	79.79	18.41	4.91	2.45	1.99	1.99	0.61	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	87.80	53.81	9.82	4.36	1.82	0.36	0.55	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	92.76	49.69	12.01	2.48	1.66	0.83	1.66	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	71.50	66.44	8.99	3.93	2.25	1.55	0.84	0.28	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	71.06	57.39	12.90	4.04	2.12	1.16	1.16	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	73.57	49.28	13.19	0.69	2.08	3.47	2.08	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	83.76	48.92	9.95	4.29	3.26	1.37	0.17	0.00	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	113.52	64.64	16.33	4.03	2.76	1.50	1.04	0.58	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	78.26	65.66	18.04	4.24	1.33	1.33	0.80	0.66	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	157.05	78.73	25.93	4.86	4.73	2.97	2.16	1.49	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	118.08	99.44	22.62	5.98	5.69	4.27	3.13	0.71	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	48.42	35.24	6.26	2.96	1.98	0.33	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	112.91	105.30	22.69	6.37	3.18	1.80	1.52	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	114.50	62.49	22.69	5.24	1.75	2.79	1.05	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	151.29	66.97	22.66	6.94	3.67	3.67	1.02	1.43	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	108.91	60.39	17.25	6.47	2.52	3.59	1.08	1.08	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	77.38	93.93	18.62	7.03	3.83	2.79	1.76	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	129.73	76.15	23.71	8.44	4.10	4.33	6.84	2.51	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	144.33	106.15	34.40	10.49	4.20	2.10	4.20	0.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	148.39	80.85	17.48	5.08	3.74	2.09	1.34	0.75	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	75.28	91.47	19.69	7.35	4.03	1.93	0.88	0.44	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	86.15	72.16	19.51	7.36	4.05	0.74	1.10	1.10	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	153.95	80.41	26.33	9.73	3.72	3.15	2.29	2.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	147.36	87.57	38.73	7.58	8.00	2.11	2.11	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	105.03	80.37	14.61	4.57	3.65	3.20	3.20	5.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	89.27	46.81	16.88	4.09	1.53	1.79	3.84	5.12	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	100.25	56.80	17.28	3.66	3.66	3.14	3.66	3.66	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	93.66	55.46	18.18	2.46	4.31	1.85	6.78	1.85	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	85.20	52.72	16.47	3.29	3.06	3.06	3.77	1.88	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	92.40	50.09	18.28	3.38	5.42	2.37	4.40	4.06	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	103.74	52.27	16.11	3.54	2.36	1.57	4.72	3.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	88.51	49.12	16.22	4.63	1.39	0.93	2.78	2.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	115.66	74.12	17.59	4.90	5.19	3.75	4.61	3.75	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	96.60	56.00	17.62	4.46	4.46	2.68	3.35	2.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	96.62	68.26	16.10	8.17	4.33	1.68	5.05	4.09	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	104.87	74.07	16.87	5.87	2.93	2.20	0.73	2.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	89.62	48.00	17.45	3.69	2.01	1.34	3.36	3.36	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	90.47	50.35	18.83	5.32	2.46	1.64	2.87	4.09	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	93.64	50.69	17.18	6.44	5.58	1.72	5.58	2.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	106.64	87.50	16.41	8.20	8.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	108.46	82.64	25.82	5.16	10.33	5.16	0.00	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	114.65	68.85	22.74	4.87	3.90	2.92	5.52	2.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	112.03	80.02	18.91	4.36	5.82	0.00	1.45	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	119.41	85.29	12.79	4.26	1.60	1.60	4.26	5.86	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	98.95	62.97	13.90	7.36	1.64	3.27	4.91	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	104.57	64.53	13.99	3.89	1.55	3.11	4.28	1.94	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	86.05	56.67	18.89	6.30	4.20	2.10	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	99.35	59.61	16.89	3.97	2.98	1.99	1.99	2.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	95.34	85.81	4.77	0.00	0.00	4.77	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	107.92	65.82	13.05	7.71	2.37	1.19	5.34	2.37	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	102.35	75.54	18.28	4.87	2.44	2.44	2.44	7.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	81.16	54.10	0.00	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	120.98	77.27	19.00	7.60	1.90	1.27	2.53	4.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	42.42	34.84	6.55	1.72	1.03	1.03	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	45.13	34.39	6.45	4.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	51.89	35.93	3.99	0.00	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	34.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	17.11	27.30	2.85	1.22	0.00	0.00	0.00	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	22.24	27.01	2.38	1.59	0.00	0.00	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	15.92	28.89	2.36	1.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	17.14	26.81	5.30	0.94	0.00	0.00	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	20.05	28.07	5.35	1.34	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	22.47	31.93	3.55	0.00	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	33.38	43.66	10.27	7.70	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	35.80	42.68	5.51	2.07	0.69	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	24.74	36.62	6.43	0.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	17.94	41.50	2.24	0.00	1.12	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	21.63	28.62	5.72	2.54	0.64	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	27.00	43.12	6.45	4.84	1.21	0.40	0.00	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	23.99	50.15	13.08	6.54	0.00	0.00	0.00	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	24.07	63.35	15.20	6.34	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	24.28	24.28	5.46	1.21	0.00	0.00	0.00	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	40.67	4.52	0.00	0.00	0.00	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	13.18	41.18	6.59	0.82	0.00	0.00	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	32.74	38.10	8.73	2.78	0.40	0.60	0.20	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	27.26	37.32	6.17	1.62	0.00	0.65	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	32.60	37.69	11.20	3.06	1.02	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	120.70	73.50	17.02	13.15	6.19	6.96	4.64	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	79.61	108.67	40.87	11.34	1.65	0.71	0.94	0.47	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	62.32	34.98	9.73	4.63	4.63	2.32	1.85	0.70	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	128.21	25.64	17.09	4.27	0.00	0.00	12.82	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	138.71	76.55	17.06	4.93	3.19	2.47	2.88	0.41	0.51
mesothelioma cell line:Mero-25	10850-111F4	147.52	106.44	42.44	7.49	2.95	1.36	2.95	0.68	0.23
mesothelioma cell line:Mero-41	10851-111F5	86.79	63.07	12.22	4.89	2.20	1.22	1.22	0.98	0.00
mesothelioma cell line:Mero-48a	10852-111F6	153.01	113.59	43.18	10.63	2.66	1.55	0.89	0.44	0.22
mesothelioma cell line:Mero-82	10853-111F7	72.80	42.05	15.51	2.63	2.63	1.58	1.05	0.26	0.53
mesothelioma cell line:Mero-83	10854-111F8	97.54	98.90	30.64	7.83	3.74	3.23	4.94	1.36	0.17
mesothelioma cell line:Mero-84	10855-111F9	75.58	47.77	13.65	3.79	2.78	2.53	3.54	0.51	0.25
mesothelioma cell line:Mero-95	10856-111G1	62.53	47.00	15.74	3.52	0.21	0.00	0.00	0.62	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	101.71	88.12	25.84	9.11	3.64	2.32	3.98	0.99	0.33
mesothelioma cell line:NCI-H226	10846-111E9	77.10	40.90	12.13	3.26	3.26	2.90	6.15	2.17	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	74.65	69.35	16.40	6.66	3.07	1.54	1.88	0.51	0.34
mesothelioma cell line:NCI-H28	10845-111E8	41.73	64.63	25.70	5.34	1.27	1.02	1.27	0.51	2.29
mesothelioma cell line:No36	10857-111G2	35.88	44.36	13.37	2.94	0.98	0.00	0.98	0.65	0.33
mesothelioma cell line:ONE58	10858-111G3	36.85	46.87	14.36	3.52	0.54	0.27	1.35	0.81	0.27
migratory langerhans cells, donor1	11901-125F2	179.26	202.29	29.17	7.68	0.77	0.00	0.00	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	216.27	172.18	23.45	11.36	0.73	0.12	0.12	0.24	0.12
migratory langerhans cells, donor3	11903-125F4	165.12	184.51	43.79	13.82	0.00	0.18	0.00	0.54	0.90
mixed mullerian tumor cell line:HTMMT	10689-109F5	37.22	42.44	13.39	5.55	0.00	0.00	0.00	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	45.57	71.63	26.70	6.57	1.06	0.21	0.85	0.42	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	85.00	81.32	19.81	5.07	0.69	0.23	0.00	0.23	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	103.71	93.24	19.98	6.47	0.76	0.19	0.19	0.57	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	54.51	61.91	44.72	13.67	0.18	0.00	0.00	0.00	0.55
myeloma cell line:PCM6	10474-106I6	80.06	74.13	9.09	5.93	0.40	0.00	0.00	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	102.98	120.73	28.92	10.65	3.55	2.03	1.01	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	45.50	38.25	5.49	1.37	0.78	0.39	0.59	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	80.89	44.68	33.20	6.46	0.00	0.00	0.00	0.22	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	73.54	48.98	27.58	6.62	0.15	0.00	0.00	0.15	0.59
nasal epithelial cells, donor2	12227-129F4	120.89	33.12	19.32	4.97	1.10	0.55	0.00	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	4.83	12.42	26.23	4.60	0.00	0.00	0.00	0.00	0.69
neuroblastoma cell line:NB-1	10539-107G8	26.00	41.16	41.72	7.11	0.56	0.00	0.00	0.19	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	4.85	16.24	40.28	3.16	0.00	0.00	0.00	0.00	0.21
neuroblastoma cell line:NH-12	10555-107I6	10.62	16.77	31.49	5.22	0.19	0.00	0.00	0.00	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	1.19	5.69	48.39	5.93	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	4.28	4.28	43.55	1.58	0.00	0.00	0.00	0.16	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	14.29	26.77	46.09	4.83	0.00	0.00	0.00	0.00	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	1.91	5.09	39.42	0.64	0.00	0.00	0.00	0.00	2.54
neurofibroma cell line:Hs 53.T	10729-110A9	203.09	122.70	25.02	10.65	5.86	7.72	3.99	3.46	0.00
neutrophil PMN, donor1	12133-128D9	178.50	327.25	104.12	29.75	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	172.65	185.93	79.68	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	236.77	236.77	47.35	37.88	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	51.92	48.71	35.52	4.57	0.17	0.00	1.18	0.17	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	12.01	10.41	20.81	3.20	0.00	0.00	0.00	0.00	3.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	111.89	71.50	16.35	4.17	4.49	3.21	2.89	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	141.10	73.31	19.44	4.73	4.73	3.42	4.99	0.79	0.00
nucleus accumbens, adult, pool1	10037-101F1	13.87	16.87	32.53	1.69	0.37	0.28	0.19	0.37	2.25
occipital cortex - adult, donor10196	10172-103C1	10.30	20.60	30.91	0.00	2.06	0.00	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	20.40	20.93	19.86	1.61	0.27	0.00	0.00	0.27	1.61
occipital cortex, newborn, donor10223	10355-105E4	21.11	19.29	80.43	2.91	0.36	0.00	0.00	0.36	2.18
occipital lobe, adult, donor1	10076-102A4	6.56	15.22	37.00	2.10	0.79	0.00	0.00	0.00	1.31
occipital lobe, fetal, donor1	10073-102A1	4.72	19.74	96.12	3.43	0.00	0.00	0.43	0.00	2.57
occipital pole, adult, pool1	10036-101E9	9.78	13.17	30.98	1.73	0.39	0.00	0.08	0.16	3.47
olfactory region, adult	10195-103E6	12.42	15.86	24.26	0.76	0.57	0.00	0.00	0.00	0.76
optic nerve, donor1	10277-104E7	20.01	32.02	18.01	2.00	0.00	0.00	2.00	2.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	74.50	54.68	13.33	5.13	1.25	0.00	0.11	0.00	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	23.49	27.89	22.12	2.06	0.27	0.00	0.00	0.00	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	50.12	30.82	16.59	2.37	0.68	0.34	0.17	0.00	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	57.29	40.20	17.21	3.23	0.12	0.00	0.12	0.00	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	96.72	78.78	16.76	5.88	5.59	3.82	3.23	1.76	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	38.31	92.50	45.78	8.41	1.87	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	67.43	47.71	21.84	5.09	0.64	0.21	0.21	0.21	0.00
ovary, adult, pool1	10020-101D2	55.99	58.87	32.23	8.47	1.57	0.52	0.52	0.26	0.52
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	68.75	77.54	42.35	8.80	0.55	0.18	0.18	0.37	0.55
pancreas, adult, donor1	10049-101G4	28.22	19.75	9.41	3.76	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	30.19	65.13	25.16	6.99	0.00	0.00	0.00	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	83.13	48.38	19.08	5.79	0.85	0.17	0.34	0.17	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	60.27	52.82	13.25	3.15	0.17	0.17	0.17	0.17	0.50
paracentral gyrus, adult, pool1	10035-101E8	11.26	14.00	30.29	1.56	0.00	0.00	0.09	0.09	2.29
parietal cortex, adult, donor10258	10373-105G4	7.34	13.21	19.82	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	15.05	12.23	28.21	0.94	0.00	0.00	0.00	0.94	1.88
parietal lobe, adult, donor10252	10157-103A4	10.55	9.41	16.53	2.28	0.00	0.00	0.00	0.00	2.28
parietal lobe, adult, pool1	10034-101E7	13.83	14.89	30.49	2.64	0.35	0.09	0.18	0.44	1.85
parietal lobe, fetal, donor1	10072-101I9	14.55	20.37	109.59	3.88	0.97	0.00	0.00	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	13.83	19.81	63.93	1.87	0.37	0.00	0.75	0.00	1.87
parotid gland, adult	10199-103F1	65.37	40.70	18.50	1.85	0.00	0.00	0.00	0.00	3.08
penis, adult	10200-103F2	70.90	51.03	26.32	4.30	0.54	0.00	1.07	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	2.60	4.65	63.59	1.12	0.19	0.19	0.19	0.00	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	59.15	62.36	18.94	3.79	0.87	0.15	0.15	0.29	0.87
pineal gland - adult, donor10196	10179-103C8	42.57	51.60	60.63	1.29	0.00	0.00	0.65	0.65	3.87
pineal gland, adult, donor10252	10160-103A7	73.43	71.66	72.84	7.11	1.78	0.00	0.00	0.00	4.15
pineal gland, adult, donor10258	10377-105G8	44.52	73.99	47.03	5.02	0.63	0.63	0.00	0.00	3.14
pituitary gland - adult, donor10196	10180-103C9	30.35	45.53	31.37	6.07	0.00	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	29.19	33.36	25.54	3.65	0.00	0.00	0.00	0.00	3.13
pituitary gland, adult, donor10258	10378-105G9	18.73	55.33	22.13	3.40	0.85	0.00	0.00	0.00	0.85
placenta, adult, pool1	10021-101D3	48.48	51.06	14.30	3.44	0.32	0.32	0.75	0.54	1.08
plasma cell leukemia cell line:ARH-77	10840-111E3	30.46	31.25	29.53	3.58	0.40	0.00	0.00	0.26	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	41.87	37.82	10.27	4.05	1.40	0.31	0.93	0.00	0.16
pons, adult, pool1	10033-101E6	13.25	16.44	20.23	1.89	0.09	0.09	0.00	0.26	3.18
postcentral gyrus, adult, pool1	10032-101E5	11.68	12.20	30.77	1.83	0.44	0.00	0.00	0.17	2.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	31.37	60.65	33.46	10.46	0.00	0.00	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	22.03	44.06	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	35.21	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	53.75	77.06	32.92	8.89	1.02	0.29	0.00	0.00	1.46
prostate cancer cell line:PC-3	10439-106E7	52.09	48.64	14.52	5.99	0.36	0.18	0.18	0.36	0.36
prostate, adult, pool1	10022-101D4	65.48	59.77	20.77	5.80	1.54	0.63	0.36	0.73	0.27
putamen, adult, donor10196	10176-103C5	9.44	10.62	26.20	1.89	0.24	0.00	0.00	0.71	0.71
putamen, adult, donor10252	10152-102I8	33.33	25.49	11.76	3.92	0.00	0.00	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	9.84	20.76	37.16	2.19	1.09	0.00	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	7.25	18.12	13.05	0.97	0.00	0.00	0.24	0.24	0.48
putamen, newborn, donor10223	10365-105F5	19.49	15.74	23.24	2.25	0.00	0.00	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	20.66	20.66	10.47	4.07	0.00	0.00	0.29	0.00	0.00
rectum, fetal, donor1	10067-101I4	72.33	80.68	45.90	9.74	2.78	0.00	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	58.09	36.68	10.60	3.18	1.06	0.21	0.42	0.42	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	15.33	16.98	5.80	0.83	1.24	0.00	0.00	0.00	0.41
retina, adult, pool1	10030-101E3	61.73	57.25	25.35	4.77	1.49	0.60	0.30	0.40	1.79
retinoblastoma cell line:Y79	10475-106I7	16.89	34.03	34.29	5.72	0.26	0.00	0.00	0.00	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	30.98	39.59	16.72	2.46	0.37	0.00	0.25	0.25	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	24.18	40.49	9.84	5.06	0.00	0.00	0.00	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	117.47	97.01	10.61	5.30	5.30	3.03	5.30	0.76	0.00
salivary acinar cells, donor1	11771-123I7	66.04	22.66	9.39	2.91	0.00	0.00	0.00	0.00	0.00
salivary acinar cells, donor2	11772-123I8	77.66	20.79	12.53	2.20	0.14	0.00	0.00	0.00	0.41
salivary acinar cells, donor3	11773-123I9	52.30	19.86	9.27	0.00	1.32	0.00	0.00	0.66	0.66
salivary gland, adult, pool1	10093-102C3	43.47	52.05	22.31	4.58	0.00	0.00	0.00	0.00	2.86
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	65.59	65.09	14.84	7.50	0.51	0.25	0.34	0.25	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	69.59	66.53	12.93	7.05	1.29	0.12	0.24	0.12	0.00
seminal vesicle, adult	10201-103F3	69.84	49.73	15.87	1.06	1.06	1.06	0.53	0.53	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	47.37	29.88	15.06	2.92	0.73	0.49	0.49	0.00	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	22.90	23.40	9.81	4.78	0.25	0.00	0.25	0.25	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	45.16	32.11	21.07	2.01	1.00	1.00	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	38.82	30.09	16.12	4.84	0.00	0.13	0.13	0.40	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	54.71	30.17	16.69	3.09	0.11	0.00	0.00	0.11	1.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	52.64	30.45	6.84	2.84	1.03	0.00	0.26	0.00	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	23.41	41.14	14.90	1.42	1.42	0.00	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	38.86	39.22	15.95	5.04	0.00	0.24	0.12	0.24	0.60
skeletal muscle, fetal, donor1	10066-101I3	23.12	59.30	21.11	22.11	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	40.71	27.14	13.57	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	33.46	39.77	30.30	1.26	0.63	0.00	0.00	0.00	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	31.02	61.70	29.02	6.67	0.00	0.67	0.00	0.00	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	12.61	23.64	16.39	0.95	0.00	0.00	0.00	0.00	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	10.79	56.28	69.39	7.71	0.00	0.00	0.00	0.19	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	54.23	30.49	16.32	2.80	0.33	0.00	0.00	0.16	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	6.59	14.48	37.32	4.34	0.00	0.00	0.00	0.00	1.29
small cell lung carcinoma cell line:WA-hT	10562-108A4	31.16	56.22	22.23	3.49	0.65	0.00	0.22	0.00	0.44
small intestine, adult, pool1	10024-101D6	128.64	64.02	19.11	5.02	0.60	0.12	0.12	0.00	1.91
small intestine, fetal, donor1	10064-101I1	76.90	47.67	30.22	4.91	0.74	0.25	0.00	0.00	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	76.42	37.44	13.34	1.54	0.51	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	110.62	84.26	33.34	5.69	2.33	1.03	1.29	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	39.13	34.84	12.87	2.14	0.00	0.00	0.00	0.00	0.80
spinal cord - adult, donor10196	10181-103D1	21.56	26.15	22.71	3.44	0.92	0.23	0.23	0.69	1.15
spinal cord, adult, donor10252	10159-103A6	28.39	26.02	29.57	1.58	0.39	0.00	0.00	0.39	1.97
spinal cord, adult, donor10258	10369-105F9	10.38	34.59	18.68	0.00	0.00	0.00	0.00	0.00	1.38
spinal cord, fetal, donor1	10056-101H2	31.10	31.71	45.74	2.44	1.22	0.00	0.00	0.00	2.44
spinal cord, newborn, donor10223	10359-105E8	32.60	40.87	22.50	2.76	0.00	0.92	0.00	0.00	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	155.93	117.24	26.59	6.42	7.92	9.71	8.81	4.03	0.15
spleen, adult, pool1	10025-101D7	61.90	54.74	21.92	4.85	0.66	0.00	0.22	0.00	0.33
spleen, fetal, pool1	10044-101F8	57.53	53.16	29.56	6.12	0.72	0.16	0.40	0.48	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	71.73	54.55	24.84	8.38	0.31	0.00	0.10	0.10	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	37.41	40.25	11.96	3.99	0.57	0.38	0.57	0.00	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	42.98	63.60	21.32	5.59	1.05	0.70	0.00	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	64.50	48.48	22.67	3.52	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	46.49	35.34	27.69	7.54	0.56	0.11	0.00	0.00	1.13
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	21.60	28.80	19.49	2.54	0.00	0.00	0.00	0.00	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	74.46	115.08	22.00	6.35	1.27	0.85	0.00	0.42	0.85
stomach, fetal, donor1	10062-101H8	85.44	70.49	24.56	1.07	4.27	1.07	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	58.11	26.77	31.33	3.42	0.00	0.00	0.00	0.00	1.71
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	27.62	31.78	23.26	3.74	0.21	0.00	0.00	0.21	0.62
substantia nigra, adult, donor10258	10371-105G2	5.69	33.62	20.69	1.55	0.00	0.00	0.52	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	27.56	34.62	21.90	4.24	0.00	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	16.97	19.72	48.83	5.27	0.46	0.00	0.00	0.23	0.69
temporal lobe, adult, pool1	10031-101E4	15.51	17.12	36.88	1.53	0.00	0.08	0.00	0.25	1.44
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	11.40	15.67	98.29	4.99	0.00	0.00	0.00	0.00	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	14.50	13.63	73.84	3.96	0.00	0.00	0.00	0.44	1.32
tenocyte, donor1	11763-123H8	116.25	45.38	18.85	2.09	3.49	1.75	2.79	1.05	0.35
tenocyte, donor2	11765-123I1	46.93	33.95	11.45	1.91	3.05	0.76	1.14	0.00	0.76
tenocyte, donor3	11768-123I4	67.83	48.93	20.02	3.71	2.22	4.45	5.93	4.82	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	33.48	74.61	61.53	14.11	0.00	0.00	0.17	0.00	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	31.75	35.30	31.60	4.62	0.46	0.00	0.00	0.15	0.46
teratocarcinoma cell line:PA-1	10807-111A6	36.42	55.17	91.90	12.40	0.15	0.15	0.00	0.00	1.55
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	88.99	66.90	77.69	13.84	0.25	0.13	0.00	0.13	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	29.88	24.96	120.26	6.05	0.00	0.00	0.00	0.00	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	62.93	32.39	52.57	6.33	0.11	0.00	0.11	0.00	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	17.91	22.47	121.49	7.17	0.00	0.00	0.00	0.00	1.63
testis, adult, pool1	10026-101D8	49.82	55.62	34.36	11.38	0.75	0.32	1.50	1.18	4.94
testis, adult, pool2	10096-102C6	27.97	69.47	65.41	19.40	0.00	0.45	1.80	4.06	9.92
thalamus - adult, donor10196	10168-103B6	20.98	28.70	29.81	1.10	1.10	0.00	0.00	3.31	2.21
thalamus, adult, donor10252	10154-103A1	17.97	25.94	19.85	2.03	0.16	0.00	0.16	0.00	1.56
thalamus, adult, donor10258, tech_rep1	10370-105G1	7.70	13.86	13.86	0.00	0.00	0.00	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	12.02	19.27	8.40	0.82	0.00	0.00	0.16	0.00	1.65
thalamus, newborn, donor10223	10366-105F6	15.53	22.44	21.29	2.30	0.00	0.00	0.00	0.00	1.15
throat, adult	10209-103G2	55.43	29.71	20.97	1.50	0.00	0.00	0.00	0.00	1.50
throat, fetal, donor1	10061-101H7	38.70	46.32	33.82	3.96	0.61	0.00	0.30	0.30	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	11.73	17.69	37.96	2.38	0.00	0.00	0.00	0.00	2.38
thymus, adult, pool1	10027-101D9	34.60	26.15	181.33	3.68	1.29	0.80	0.30	0.40	7.75
thymus, fetal, pool1	10043-101F7	35.64	31.69	136.74	4.88	0.83	0.21	0.42	0.10	3.01
thyroid carcinoma cell line:KHM-5M	10776-110G2	86.42	46.80	10.64	3.99	1.46	0.40	0.13	0.00	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	65.38	55.32	27.10	7.26	1.26	0.70	0.84	0.42	0.84
thyroid, adult, pool1	10028-101E1	69.24	63.08	37.70	5.60	0.84	0.37	0.19	0.28	4.39
thyroid, fetal, donor1	10060-101H6	63.02	48.78	39.29	7.65	0.53	0.00	0.53	0.26	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	12.32	40.04	15.40	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	48.61	30.70	15.35	1.63	0.00	0.00	0.00	0.00	0.70
tongue, fetal, donor1	10059-101H5	65.81	58.72	26.01	4.34	0.39	0.00	0.00	0.39	0.00
tonsil, adult, pool1	10047-101G2	78.54	52.29	58.20	5.31	0.30	0.00	0.00	0.30	1.80
trachea, adult, pool1	10029-101E2	71.90	46.63	16.11	3.19	0.82	0.41	0.25	0.33	1.31
trachea, fetal, donor1	10058-101H4	50.39	34.24	22.31	4.23	0.77	0.00	0.77	1.54	2.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	144.54	97.78	24.80	6.38	3.19	3.54	3.54	2.13	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	41.54	37.39	14.69	4.05	0.51	0.10	0.00	0.30	0.91
transitional-cell carcinoma cell line:JMSU1	10492-107B6	37.13	41.52	19.12	7.05	0.63	0.31	0.16	0.00	0.16
tridermal teratoma cell line:HGRT	10694-109G1	98.93	87.52	15.22	7.61	9.51	3.81	5.71	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	45.54	43.00	10.41	3.47	0.85	0.08	0.25	0.00	0.17
umbilical cord, fetal, donor1	10057-101H3	56.34	41.73	18.78	2.09	2.09	0.00	2.09	2.09	0.00
uterus, adult, pool1	10100-102D1	83.27	122.17	41.12	9.04	3.24	0.68	0.00	1.37	0.68
uterus, fetal, donor1	10055-101H1	65.53	74.23	33.28	9.73	3.07	1.02	1.02	0.00	0.00
vagina, adult	10204-103F6	52.99	40.71	10.99	3.88	2.58	1.29	0.65	0.65	0.00
vein, adult	10191-103E2	56.33	36.83	60.50	2.41	0.44	0.00	1.10	0.22	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	50.20	63.55	31.51	8.81	0.00	0.00	0.00	0.27	0.27